Below are some recent publications from our members;
Chan JC, Diakos CI, Chan DL, Engel A, Pavlakis N, Gill A, Clarke SJ. A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement. Ann Surg. 2017 Apr 7. doi: 10.1097/SLA.0000000000002251
Byrne, H.L., Gholami, Y., Kuncic, Z. Impact of fluorescence emission from gold atoms on surrounding biological tissue – Implications for nanoparticle radio-enhancement. Physics in Medicine and Biology . 2017: 62 ( 8 ) pp. 3097 – 3110.
Perry, J.R., Laperriere, N., O’Callaghan, C.J., Brandes, A.A., Menten, J., Phillips, C., Fay, M., Nishikawa, R., Cairncross, J.G., Roa, W., Osoba, D., Rossiter, J.P., Sahgal, A., Hirte, H., Laigle-Donadey, F., Franceschi, E., Chinot, O., Golfinopoulos, V., Fariselli, L., Wick, A., Feuvret, L., Back, M., Tills, M., Winch, C., Baumert, B.G., Wick, W., Ding, K., Mason, W.P. Short-course radiation plus temozolomide in elderly patients with glioblastoma. New England Journal of Medicine. 2017: 376 ( 11 ) pp. 1027 – 1037
A full list of member publications can be found here;
Back, M., M. LeMottee, C. Crasta, D. Bailey, H. Wheeler, L. Guo and T. Eade (2017). “Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma.” Radiation Oncology 12(1).
Bell, L. J., T. Eade, A. Kneebone, G. Hruby, F. Alfieri, R. Bromley, K. Grimberg, M. Barnes and J. T. Booth (2017). “Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment.” Journal of Medical Radiation Sciences 64(1): 25-34.
Bowyer, S., P. Prithviraj, P. Lorigan, J. Larkin, G. McArthur, V. Atkinson, M. Millward, M. Khou, S. Diem, S. Ramanujam, B. Kong, E. Liniker, A. Guminski, P. Parente, M. C. Andrews, S. Parakh, J. Cebon, G. V. Long, M. S. Carlino and O. Klein (2017). “Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’.” British Journal of Cancer.
Bray, V. J., H. M. Dhillon, M. L. Bell, M. Kabourakis, M. H. Fiero, D. Yip, F. Boyle, M. A. Price and J. L. Vardy (2017). “Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy.” Journal of Clinical Oncology 35(2): 217-225.
Brennan, M. E., M. McKessar, K. Snook, I. Burgess and A. J. Spillane (2017). “Impact of selective use of breast MRI on surgical decision-making in women with newly diagnosed operable breast cancer.” Breast 32: 135-143.
Byrne, H. L., Y. Gholami and Z. Kuncic (2017). “Impact of fluorescence emission from gold atoms on surrounding biological tissue – Implications for nanoparticle radio-enhancement.” Physics in Medicine and Biology 62(8): 3097-3110.
Chan, D. L., K. M. Sjoquist, D. Goldstein, T. J. Price, A. J. Martin, Y. J. Bang, Y. K. Kang and N. Pavlakis (2017). “The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.” PLoS ONE 12(2).
Chan, D. L. H., N. Pavlakis, G. P. Schembri, E. J. Bernard, E. Hsiao, A. Hayes, T. Barnes, C. Diakos, M. Khasraw, J. Samra, E. Eslick, P. J. Roach, A. Engel, S. J. Clarke and D. L. Bailey (2017). “Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: Proposal for a novel grading scheme with prognostic significance.” Theranostics 7(5): 1149-1158.
Chan, J. C. Y., C. I. Diakos, D. L. H. Chan, A. Engel, N. Pavlakis, A. Gill and S. J. Clarke (2017). “A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.” Annals of Surgery.
Chang, J. H., S. Gandhidasan, R. Finnigan, D. Whalley, R. Nair, A. Herschtal, T. Eade, A. Kneebone, J. Ruben, M. Foote and S. Siva (2017). “Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases.” Clinical Oncology.
Choong, E. S., S. Lo, M. Drummond, G. B. Fogarty, A. M. Menzies, A. Guminski, B. Shivalingam, K. Clarke, G. V. Long and A. M. Hong (2017). “Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.” European Journal of Cancer 75: 169-178.
Chua, T. C., L. O. Roseverne, P. D. Edwards, N. S. Sandanayake, S. Cho, M. Ooi and J. S. Samra (2017). “Gastrointestinal: Intractable delayed gastrointestinal bleeding after pancreatoduodenectomy.” Journal of Gastroenterology and Hepatology (Australia) 32(4): 735.
Clement, S., W. Chen, A. G. Anwer and E. M. Goldys (2017). “Verteprofin conjugated to gold nanoparticles for fluorescent cellular bioimaging and X-ray mediated photodynamic therapy.” Microchimica Acta: 1-7.
Clement, S., M. Sobhan, W. Deng, E. Camilleri and E. M. Goldys (2017). “Nanoparticle-mediated singlet oxygen generation from photosensitizers.” Journal of Photochemistry and Photobiology A: Chemistry 332: 66-71.
Crookes, T. R., R. A. Scolyer, S. Lo, M. Drummond and A. J. Spillane (2017). “Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.” Annals of Surgical Oncology: 1-8.
Crumbaker, M., A. Guminski, H. Gurney, D. Sabanathan, S. Wong and N. Pavlakis (2017). “Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia.” Asia-Pacific Journal of Clinical Oncology.
Elsner, K., D. Naehrig, G. K. B. Halkett and H. M. Dhillon (2017). “Reduced patient anxiety as a result of radiation therapist-led psychosocial support: A systematic review.” Journal of Medical Radiation Sciences.
Feain, I. J., L. Court, J. R. Palta, S. Beddar and P. Keall (2017). “Innovations in Radiotherapy Technology.” Clinical Oncology 29(2): 120-128.
Flitcroft, K., M. Brennan and A. Spillane (2017). “Making decisions about breast reconstruction: A systematic review of patient-reported factors influencing choice.” Quality of Life Research: 1-33.
François, K., E. Lobb, S. Barclay and L. Forbat (2017). “The nature of conflict in palliative care: A qualitative exploration of the experiences of staff and family members.” Patient Education and Counseling.
Gerace, D., R. Martiniello-Wilks, N. T. Nassif, S. Lal, R. Steptoe and A. M. Simpson (2017). “CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: A path to clinical success?” Stem Cell Research and Therapy 8(1).
Gifford, G., S. Gabrielli, A. Gill, M. Greenwood, K. Wong, G. Best, D. Nevell, K. McIlroy, D. Kliman, L. Ilmay-Gillespie, C. Tiley, S. Miranda, T. Armytage and W. Stevenson (2017). “Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts.” British Journal of Haematology.
Gill, P., T. C. Chua, Y. Huang, S. Mehta, A. Mittal, A. J. Gill and J. S. Samra (2017). “Pancreatoduodenectomy and the risk of complications from perioperative fluid administration.” ANZ Journal of Surgery.
Green, T. N., J. R. Hamilton, M. Morel-Kopp, Z. Zheng, T. T. Chen, J. I. Hearn, P. P. Sun, J. U. Flanagan, D. Young, P. A. Barber, M. J. During, C. M. Ward and M. L. Kalev-Zylinska (2017). “Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis.” Platelets: 1-13.
Gzell, C., M. Back, H. Wheeler, D. Bailey and M. Foote (2017). “Radiotherapy in Glioblastoma: the Past, the Present and the Future.” Clinical Oncology 29(1): 15-25.
Haddad, R. I., M. Schlumberger, L. J. Wirth, E. J. Sherman, M. H. Shah, B. Robinson, C. E. Dutcus, A. Teng, A. G. Gianoukakis and S. I. Sherman (2017). “Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes.” Endocrine: 1-8.
Hammarberg, K., E. Sullivan, N. Javid, G. Duncombe, L. Halliday, F. Boyle, C. Saunders, A. Ives, J. E. Dickinson and J. Fisher (2017). “Health care experiences among women diagnosed with gestational breast cancer.” European Journal of Cancer Care.
Hatoum, D., D. Yagoub, A. Ahadi, N. T. Nassif and E. M. McGowan (2017). “Annexin/S100A protein family regulation through p14ARF-p53 activation: A role in cell survival and predicting treatment outcomes in breast cancer.” PLoS ONE 12(1).
Hosoda, W., P. Chianchiano, J. F. Griffin, M. E. Pittman, L. A. A. Brosens, M. Noë, J. Yu, K. Shindo, M. Suenaga, N. Rezaee, R. Yonescu, Y. Ning, J. Albores-Saavedra, N. Yoshizawa, K. Harada, A. Yoshizawa, K. Hanada, S. Yonehara, M. Shimizu, T. Uehara, J. S. Samra, A. J. Gill, C. L. Wolfgang, M. G. Goggins, R. H. Hruban and L. D. Wood (2017). “Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.” Journal of Pathology 242(1): 16-23.
Huang, Y., T. C. Chua, A. J. Gill and J. S. Samra (2017). “Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: A meta-analysis.” Pancreatology.
Hugo, G. D., E. Weiss, W. C. Sleeman, S. Balik, P. J. Keall, J. Lu and J. F. Williamson (2017). “A longitudinal four-dimensional computed tomography and cone beam computed tomography dataset for image-guided radiation therapy research in lung cancer.” Medical physics 44(2): 762-771.
Humphris, J. L., A. M. Patch, K. Nones, P. J. Bailey, A. L. Johns, S. McKay, D. K. Chang, D. K. Miller, M. Pajic, K. S. Kassahn, M. C. J. Quinn, T. J. C. Bruxner, A. N. Christ, I. Harliwong, S. Idrisoglu, S. Manning, C. Nourse, E. Nourbakhsh, A. Stone, P. J. Wilson, M. Anderson, J. L. Fink, O. Holmes, S. Kazakoff, C. Leonard, F. Newell, N. Waddell, S. Wood, R. S. Mead, Q. Xu, J. Wu, M. Pinese, M. J. Cowley, M. D. Jones, A. M. Nagrial, V. T. Chin, L. A. Chantrill, A. Mawson, A. Chou, C. J. Scarlett, A. V. Pinho, I. Rooman, M. Giry-Laterriere, J. S. Samra, J. G. Kench, N. D. Merrett, C. W. Toon, K. Epari, N. Q. Nguyen, A. Barbour, N. Zeps, N. B. Jamieson, C. J. McKay, C. R. Carter, E. J. Dickson, J. S. Graham, F. Duthie, K. Oien, J. Hair, J. P. Morton, O. J. Sansom, R. Grützmann, R. H. Hruban, A. Maitra, C. A. Iacobuzio-Donahue, R. D. Schulick, C. L. Wolfgang, R. A. Morgan, R. T. Lawlor, B. Rusev, V. Corbo, R. Salvia, I. Cataldo, G. Tortora, M. A. Tempero, O. Hofmann, J. R. Eshleman, C. Pilarsky, A. Scarpa, E. A. Musgrove, A. J. Gill, J. V. Pearson, S. M. Grimmond, N. Waddell and A. V. Biankin (2017). “Hypermutation In Pancreatic Cancer.” Gastroenterology 152(1): 68-74.e62.
Itchins, M., P. A. Ascierto, A. M. Menzies, M. Oatley, S. Lo, D. Douraghi-Zadeh, T. Harrington, R. Maher, A. M. Grimaldi and A. Guminski (2017). “A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy.” Melanoma Research.
Jabbour, J., H. M. Dhillon, H. L. Shepherd, P. Sundaresan, C. Milross and J. R. Clark (2017). “Challenges in Producing Tailored Internet Patient Education Materials.” International Journal of Radiation Oncology Biology Physics 97(4): 866-867.
Jabbour, J., C. Milross, P. Sundaresan, A. Ebrahimi, H. L. Shepherd, H. M. Dhillon, G. Morgan, B. Ashford, M. Abdul-Razak, E. Wong, M. Veness, C. E. Palme, C. Froggatt, R. Cohen, R. Ekmejian, J. Tay, D. Roshan and J. R. Clark (2017). “Education and support needs in patients with head and neck cancer: A multi-institutional survey.” Cancer.
Jin, F., J. M. Roberts, A. E. Grulich, I. M. Poynten, D. A. Machalek, A. Cornall, S. Phillips, D. Ekman, R. L. McDonald, R. J. Hillman, D. J. Templeton, A. Farnsworth, S. M. Garland, C. K. Fairley, S. N. Tabrizi and S. r. t. on behalf of the (2017). “The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.” AIDS.
Jones, J. A., T. Robak, J. R. Brown, F. T. Awan, X. Badoux, S. Coutre, J. Loscertales, K. Taylor, E. Vandenberghe, M. Wach, N. Wagner-Johnston, L. Ysebaert, L. Dreiling, R. Dubowy, G. Xing, I. W. Flinn and C. Owen (2017). “Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.” The Lancet Haematology 4(3): e114-e126.
Joo, L. J. S., J. T. Zhao, M. L. Gild, A. R. Glover and S. B. Sidhu (2017). “Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.” Molecular and Cellular Endocrinology.
Juneja, P., E. Colvill, A. Kneebone, T. Eade, J. A. Ng, D. I. Thwaites, P. Keall, R. Kaur, P. Poulsen and J. T. Booth (2017). “Quantification of intrafraction prostate motion and its dosimetric effect on VMAT.” Australasian Physical and Engineering Sciences in Medicine: 1-8.
Keall, P., D. T. Nguyen, R. O’Brien, J. Booth, P. Greer, P. Poulsen, V. Gebski, A. Kneebone and J. Martin (2017). “Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: The TROG 15.01 SPARK trial.” BMC Cancer 17(1).
Kim, E., M. J. Wright, L. Sioson, T. Novos, A. J. Gill, D. E. Benn, C. White, T. Dwight and R. J. Clifton-Bligh (2017). “Utility of the succinate: Fumarate ratio for assessing SDH dysfunction in different tumor types.” Molecular Genetics and Metabolism Reports 10: 45-49.
Lee, A., D. L. Chan, M. H. Wong, B. T. Li, S. Lumba, S. J. Clarke, J. Samra and N. Pavlakis (2017). “Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors.” Neuroendocrinology 104(3): 209-222.
Lim, E., J. L. Vardy, B. Oh and H. M. Dhillon (2017). “Comparison of integrative medicine centers in the USA and Germany: a mixed method study.” Supportive Care in Cancer: 1-8.
Lim, E. J., J. L. Vardy, B. S. Oh and H. M. Dhillon (2017). “A Scoping Review on Models of Integrative Medicine: What Is Known from the Existing Literature?” Journal of Alternative and Complementary Medicine 23(1): 8-17.
Linton, A., M. Soeberg, R. Broome, S. Kao and N. van Zandwijk (2017). “Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.” Respirology.
Liu, G., K. Zhang, K. Ma, A. Care, M. R. Hutchinson and E. M. Goldys (2017). “Graphene quantum dot based “switch-on” nanosensors for intracellular cytokine monitoring.” Nanoscale 9(15): 4934-4943.
Maltby, K. F., C. R. Sanderson, E. A. Lobb and J. L. Phillips (2017). “Sleep disturbances in caregivers of patients with advanced cancer: A systematic review.” Palliative and Supportive Care 15(1): 125-140.
Menzies, A. M. and G. V. Long (2017). “Optimum dosing of ipilimumab in melanoma: Too little, too late?” The Lancet Oncology.
Monterosso, L., K. Taylor, V. Platt, E. Lobb, M. Krishnasamy, T. Musiello, C. Bulsara, K. Stratton and D. Joske (2017). “A qualitative study of the post-treatment experiences and support needs of survivors of lymphoma.” European Journal of Oncology Nursing 28: 62-68.
Montillo, M., S. O’Brien, A. Tedeschi, J. C. Byrd, C. Dearden, D. Gill, J. R. Brown, J. C. Barrientos, S. P. Mulligan, R. R. Furman, F. Cymbalista, C. Plascencia, S. Chang, E. Hsu, D. F. James and P. Hillmen (2017). “Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study.” Blood Cancer Journal 7(2).
Morton, R. L., A. Tran, J. Y. Vessey, N. Rowbotham, J. Winstanley, K. Shannon, A. J. Spillane, J. Stretch, J. F. Thompson and R. P. M. Saw (2017). “Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.” Annals of Surgical Oncology: 1-9.
Nahm, C. B., P. R. de Reuver, T. J. Hugh, A. Pearson, A. J. Gill, J. S. Samra and A. Mittal (2017). “Intra-Operative Amylase Concentration in Peri-Pancreatic Fluid Predicts Pancreatic Fistula After Distal Pancreatectomy.” Journal of Gastrointestinal Surgery: 1-7.
Nahm, C. B., I. Norton, S. Cho, A. J. Gill, J. Samra and A. Mittal (2017). “Pancreatic cystic lesions: Sorting benign from malignant.” Medicine Today 18(4): 55-61.
Naidoo, J., X. Wang, K. M. Woo, T. Iyriboz, D. Halpenny, J. Cunningham, J. E. Chaft, N. H. Segal, M. K. Callahan, A. M. Lesokhin, J. Rosenberg, M. H. Voss, C. M. Rudin, H. Rizvi, X. Hou, K. Rodriguez, M. Albano, R. A. Gordon, C. Leduc, N. Rekhtman, B. Harris, A. M. Menzies, A. D. Guminski, M. S. Carlino, B. Y. Kong, J. D. Wolchok, M. A. Postow, G. V. Long and M. D. Hellmann (2017). “Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy.” Journal of Clinical Oncology 35(7): 709-717.
Newall, M. K., M. Petasecca, M. Duncan, I. Fuduli, K. A. Shukaili, J. T. Booth, P. Keall, S. Corde, V. Pereveratylo, M. Lerch and A. B. Rosenfeld (2017). “Innovative detectors for quality assurance dosimetry in SBRT of stationary and movable targets.” Journal of Physics: Conference Series 777(1).
Nguyen, D. T., R. O’Brien, J. H. Kim, C. Y. Huang, L. Wilton, P. Greer, K. Legge, J. T. Booth, P. R. Poulsen, J. Martin and P. J. Keall (2017). “The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).” Radiotherapy and Oncology.
Nguyen, T. N., M. C. Morel-Kopp, D. Pepperell, R. G. Cumming, S. N. Hilmer and C. M. Ward (2017). “The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study.” Aging Clinical and Experimental Research: 1-10.
Papaioannou, A., S. Kuyucak and Z. Kuncic (2017). “Computational study of the activity, dynamics, energetics and conformations of insulin analogues using molecular dynamics simulations: Application to hyperinsulinemia and the critical residue B26.” Biochemistry and Biophysics Reports.
Perry, J. R., N. Laperriere, C. J. O’Callaghan, A. A. Brandes, J. Menten, C. Phillips, M. Fay, R. Nishikawa, J. G. Cairncross, W. Roa, D. Osoba, J. P. Rossiter, A. Sahgal, H. Hirte, F. Laigle-Donadey, E. Franceschi, O. Chinot, V. Golfinopoulos, L. Fariselli, A. Wick, L. Feuvret, M. Back, M. Tills, C. Winch, B. G. Baumert, W. Wick, K. Ding and W. P. Mason (2017). “Short-course radiation plus temozolomide in elderly patients with glioblastoma.” New England Journal of Medicine 376(11): 1027-1037.
Phillips, C., R. Jeffree and M. Khasraw (2017). “Management of breast cancer brain metastases: A practical review.” Breast 31: 90-98.
Quinn, V. F., B. Meiser, J. Kirk, K. M. Tucker, K. J. Watts, B. Rahman, M. Peate, C. Saunders, E. Geelhoed, M. Gleeson, K. Barlow-Stewart, M. Field, M. Harris, Y. C. Antill, L. Cicciarelli, K. Crowe, M. T. Bowen, G. Mitchell, P. Gregory, L. Lipton, L. McKay, J. Senior, L. Lobb, P. Crowe, A. Matthews, G. Neil, A. Parasyn, D. Thomson, J. Duffy, L. Andrews, J. Gale, J. Fox, S. Hart, C. Smythe, M. White, L. Creighton, J. D’Arcy, S. Grieve, E. Secomb, M. Henderson, J. O’Brien, C. Poliness, A. Hattam, R. Susman, O. Ung, R. Dickson, K. Moore, P. Bastick, S. Inder, J. Lynch, P. Schwartz, R. Zia, C. Mak, K. Snook, A. Spillane, J. Hopper, M. Bowman, D. Cheung, S. Edirimanne, E. Edwards, E. Elder, J. French and D. Moon (2017). “Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: A randomized controlled noninferiority trial.” Genetics in Medicine 19(4): 448-456.
Rai, R., S. Kumar, V. Batumalai, D. Elwadia, L. Ohanessian, E. Juresic, L. Cassapi, S. K. Vinod, L. Holloway, P. J. Keall and G. P. Liney (2017). “The integration of MRI in radiation therapy: collaboration of radiographers and radiation therapists.” Journal of Medical Radiation Sciences 64(1): 61-68.
Ramelan, A. H., S. Wahyuningsih and E. Goldys (2017). The Effect of Growth Temperature and V/III Flux Ratio of MOCVD Antimony Based Semiconductors on Growth Rate and Surface Morphology. MATEC Web of Conferences.
Rehman, A. U., A. G. Anwer, M. E. Gosnell, S. B. Mahbub, G. Liu and E. M. Goldys (2017). “Fluorescence quenching of free and bound NADH in hela cells determined by hyperspectral imaging and unmixing of cell autofluorescence.” Biomedical Optics Express 8(3): 1488-1498.
Scarpa, A., D. K. Chang, K. Nones, V. Corbo, A. M. Patch, P. Bailey, R. T. Lawlor, A. L. Johns, D. K. Miller, A. Mafficini, B. Rusev, M. Scardoni, D. Antonello, S. Barbi, K. O. Sikora, S. Cingarlini, C. Vicentini, S. McKay, M. C. J. Quinn, T. J. C. Bruxner, A. N. Christ, I. Harliwong, S. Idrisoglu, S. McLean, C. Nourse, E. Nourbakhsh, P. J. Wilson, M. J. Anderson, J. L. Fink, F. Newell, N. Waddell, O. Holmes, S. H. Kazakoff, C. Leonard, S. Wood, Q. Xu, S. H. Nagaraj, E. Amato, I. Dalai, S. Bersani, I. Cataldo, A. P. Dei Tos, P. Capelli, M. V. Davì, L. Landoni, A. Malpaga, M. Miotto, V. L. J. Whitehall, B. A. Leggett, J. L. Harris, J. Harris, M. D. Jones, J. Humphris, L. A. Chantrill, V. Chin, A. M. Nagrial, M. Pajic, C. J. Scarlett, A. Pinho, I. Rooman, C. Toon, J. Wu, M. Pinese, M. Cowley, A. Barbour, A. Mawson, E. S. Humphrey, E. K. Colvin, A. Chou, J. A. Lovell, N. B. Jamieson, F. Duthie, M. C. Gingras, W. E. Fisher, R. A. Dagg, L. M. S. Lau, M. Lee, H. A. Pickett, R. R. Reddel, J. S. Samra, J. G. Kench, N. D. Merrett, K. Epari, N. Q. Nguyen, N. Zeps, M. Falconi, M. Simbolo, G. Butturini, G. Van Buren, II, S. Partelli, M. Fassan, K. K. Khanna, A. J. Gill, D. A. Wheeler, R. A. Gibbs, E. A. Musgrove, C. Bassi, G. Tortora, P. Pederzoli, J. V. Pearson, N. Waddell, A. V. Biankin and S. M. Grimmond (2017). “Whole-genome landscape of pancreatic neuroendocrine tumours.” Nature 543(7643): 65-71.
Schlichtemeier, S., A. Logaraj, A. J. Gill and A. Engel (2017). “Colorectal cancer resection in the Australian nonagenarian patient.” Colorectal Disease 19(3): 243-250.
Sclafani, F., T. Y. Kim, D. Cunningham, T. W. Kim, J. Tabernero, H. J. Schmoll, J. K. Roh, S. Y. Kim, Y. S. Park, T. K. Guren, E. Hawkes, S. J. Clarke, D. Ferry, J. E. Frodin, M. Ayers, M. Nebozhyn, C. Peckitt, A. Loboda and D. J. Watkins (2017). “Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.” International Journal of Cancer 140(2): 431-439.
Shieh, C. C., V. Caillet, M. Dunbar, P. J. Keall, J. T. Booth, N. Hardcastle, C. Haddad, T. Eade and I. Feain (2017). “A Bayesian approach for three-dimensional markerless tumor tracking using kV imaging during lung radiotherapy.” Physics in Medicine and Biology 62(8): 3065-3080.
Spillane, A. J. and G. B. Mann (2017). “Surgeon knows best versus breast cancer surgical clinical trial equipoise: a plea for the sake of future trials.” ANZ Journal of Surgery 87(3): 111-112.
Suo, H., X. Zhao, Z. Zhang, T. Li, E. M. Goldys and C. Guo (2017). “Constructing multiform morphologies of YF: Er3+/Yb3+ up-conversion nano/micro-crystals towards sub-tissue thermometry.” Chemical Engineering Journal 313: 65-73.
Tailby, E. and J. Boyages (2017). “Conservation surgery and radiation therapy in early breast cancer – An update.” Australian Family Physician 46(4): 214-219.
Tan, A. C., A. B. Heimberger and M. Khasraw (2017). “Immune Checkpoint Inhibitors in Gliomas.” Current Oncology Reports 19(4).
Templeton, D. J., J. M. Roberts, I. M. Poynten, C. Law, R. J. Hillman, A. Farnsworth, C. K. Fairley, S. N. Tabrizi, S. M. Garland, A. E. Grulich, F. Jin, B. Acraman, A. Carr, S. Carroll, D. Cooper, A. Cornall, L. Crampton, K. Fairley, L. Feeney, E. Fraissard, K. Howard, M. Law, D. MacHalek, K. McCaffery, P. McGrath, R. Mellor, R. Norris, M. O’Dwyer, S. Pendlebury, K. Petoumenos, S. Phillips, I. M. Poynten, G. Prestage, A. Richards, L. Schema, D. Seeds, E. Segelov, D. Templeton, J. Thurloe, W. Tong and R. Varma (2017). “Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC).” European Journal of Cancer Prevention 26(3): 212-216.
Townend, P., P. R. de Reuver, T. C. Chua, A. Mittal, S. J. Clark, N. Pavlakis, A. J. Gill and J. S. Samra (2017). “Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: Analysis of early outcome data.” ANZ Journal of Surgery.
Vardy, J. L., V. J. Bray and H. M. Dhillon (2017). “Cancer-induced cognitive impairment: Practical solutions to reduce and manage the challenge.” Future Oncology 13(9): 767-771.
Vennin, C., V. T. Chin, S. C. Warren, M. C. Lucas, D. Herrmann, A. Magenau, P. Melenec, S. N. Walters, G. Del Monte-Nieto, J. R. W. Conway, M. Nobis, A. H. Allam, R. A. McCloy, N. Currey, M. Pinese, A. Boulghourjian, A. Zaratzian, A. A. S. Adam, C. Heu, A. M. Nagrial, A. Chou, A. Steinmann, A. Drury, D. Froio, M. Giry-Laterriere, N. L. E. Harris, T. Phan, R. Jain, W. Weninger, E. J. McGhee, R. Whan, A. L. Johns, J. S. Samra, L. Chantrill, A. J. Gill, M. Kohonen-Corish, R. P. Harvey, A. V. Biankin, T. R. J. Evans, K. I. Anderson, S. T. Grey, C. J. Ormandy, D. Gallego-Ortega, Y. Wang, M. S. Samuel, O. J. Sansom, A. Burgess, T. R. Cox, J. P. Morton, M. Pajic and P. Timpson (2017). “Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.” Science Translational Medicine 9(384).
Whelan, B., G. P. Liney, J. A. Dowling, R. Rai, L. Holloway, L. McGarvie, I. Feain, M. Barton, M. Berry, R. Wilkins and P. Keall (2017). “An MRI-compatible patient rotation system – design, construction, and first organ deformation results.” Medical physics 44(2): 581-588.
Yamaguchi, T., M. Kuriya, T. Morita, M. Agar, Y. S. Choi, C. Goh, K. B. Lingegowda, R. Lim, R. K. Y. Liu, R. MacLeod, R. Ocampo, S. Y. Cheng, T. Phungrassami, Y. P. Nguyen and S. Tsuneto (2017). “Palliative care development in the Asia-Pacific region: An international survey from the Asia Pacific Hospice Palliative Care Network (APHN).” BMJ Supportive and Palliative Care 7(1): 23-31.
Zhou, Z., J. Zheng, R. Shi, N. Zhang, J. Chen, R. Zhang, H. Suo, E. M. Goldys and C. Guo (2017). “Ab Initio Site Occupancy and Far-Red Emission of Mn4+ in Cubic-Phase La(MgTi)1/2O3 for Plant Cultivation.” ACS Applied Materials and Interfaces 9(7): 6177-6185.
Agar, M., E. S. Koh, E. Gibbs, E. H. Barnes, E. Hovey, A. Livingstone, K. Sawkins, R. Chye, M. R. Lovell, K. Clark, J. Vardy and M. King (2016). “Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.” Supportive Care in Cancer 24(3): 1209-1218.
Ahadi, M., J. Andrici, L. Sioson, A. Sheen, A. Clarkson and A. J. Gill (2016). “Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.” Human Pathology 57: 91-97.
Ahn, M. J., A. D’Cruz, J. B. Vermorken, J. P. Chen, I. Chitapanarux, H. Q. T. Dang, A. Guminski, D. Kannarunimit, T. Y. Lin, W. T. Ng, K. U. Park and A. T. C. Chan (2016). “Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.” Oral Oncology 53: 10-16.
Åkerström, T., R. Maharjan, H. Sven Willenberg, K. Cupisti, J. Ip, A. Moser, P. Stålberg, B. Robinson, K. Alexander Iwen, H. Dralle, M. K. Walz, H. Lehnert, S. Sidhu, C. Gomez-Sanchez, P. Hellman and P. Björklund (2016). “Activating mutations in CTNNB1 in aldosterone producing adenomas.” Scientific Reports 6.
Alcorso, J., K. A. Sherman, L. Koelmeyer, H. Mackie and J. Boyages (2016). “Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema.” Supportive Care in Cancer 24(1): 139-146.
Al-Eisawi, Z., P. Beale, C. Chan, J. Q. Yu, N. Proschogo, M. Molloy and F. Huq (2016). “Changes in the in vitro activity of platinum drugs when administered in two aliquots.” BMC Cancer 16(1).
Andrici, J., M. Farzin, A. Clarkson, L. Sioson, A. Sheen, N. Watson, C. W. Toon, M. Koleth, W. Stevenson and A. J. Gill (2016). “Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.” Pathology 48(4): 319-324.
Andrici, J., M. Farzin, L. Sioson, A. Clarkson, N. Watson, C. W. Toon and A. J. Gill (2016). “Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer.” Modern Pathology 29(3): 266-274.
Andrici, J., B. Goeppert, L. Sioson, A. Clarkson, M. Renner, A. Stenzinger, M. Tayao, N. Watson, M. Farzin, C. W. Toon, R. C. Smith, A. Mittal, J. S. Samra, T. J. Hugh, A. Chou, R. T. Lawlor, W. Weichert, P. Schirmacher, N. Sperandio, A. Ruzzenente, A. Scarpa and A. J. Gill (2016). “Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma.” Medicine (United States) 95(2).
Andrici, J., J. Jung, A. Sheen, L. D’Urso, L. Sioson, J. Pickett, T. R. Parkhill, B. Verdonk, K. L. Wardell, A. Singh, A. Clarkson, N. Watson, C. W. Toon and A. J. Gill (2016). “Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.” Human Pathology 51: 9-15.
Andrici, J., T. R. Parkhill, J. Jung, K. L. Wardell, B. Verdonk, A. Singh, L. Sioson, A. Clarkson, N. Watson, A. Sheen, M. Farzin, C. W. Toon and A. J. Gill (2016). “Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.” Pathology 48(4): 336-340.
Annamalai, A. K., K. Sampathkumar, S. Kane, N. S. Shetty, S. Kulkarni, V. Rangarajan, N. Purandare, P. S. Pai, A. D. Mahuvakar, R. Shanthi, G. Suriyakumar, V. Puri, S. Aram, C. Gopalakrishnan, M. Chelian, K. G. Srinivasan, A. J. Gill, M. Gurnell and R. Clifton-Bligh (2016). “Needle(s) in the haystack-synchronous multifocal tumor-induced osteomalacia.” Journal of Clinical Endocrinology and Metabolism 101(2): 390-393.
Atkinson, V., G. V. Long, A. M. Menzies, G. McArthur, M. S. Carlino, M. Millward, R. Roberts-Thomson, B. Brady, R. Kefford, A. Haydon and J. Cebon (2016). “Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.” Asia-Pacific Journal of Clinical Oncology 12: 5-12.
Badger, S., R. Macleod and A. Honey (2016). “It’s not about treatment, it’s how to improve your life: The lived experience of occupational therapy in palliative care.” Palliative and Supportive Care 14(3): 225-231.
Bailey, D. L., E. M. Eslick, G. P. Schembri and P. J. Roach (2016). “68Ga PET Ventilation and Perfusion Lung Imaging—Current Status and Future Challenges.” Seminars in Nuclear Medicine 46(5): 428-435.
Bailey, D. L., A. Lee, B. T. Li and S. J. Clarke (2016). “PET monitoring of liver directed selective internal radionuclide therapy for metastatic gastro-oesophageal cancer.” BMJ Case Reports 2016.
Bailey, D. L., B. J. Pichler, B. Gückel, H. Barthel, A. J. Beer, R. Botnar, R. Gillies, V. Goh, M. Gotthardt, R. J. Hicks, R. Lanzenberger, C. la Fougere, M. Lentschig, S. G. Nekolla, T. Niederdraenk, K. Nikolaou, J. Nuyts, D. Olego, K. Å. Riklund, A. Signore, M. Schäfers, V. Sossi, M. Suminski, P. Veit-Haibach, L. Umutlu, M. Wissmeyer and T. Beyer (2016). “Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany.” Molecular Imaging and Biology: 1-14.
Bailey, P., D. K. Chang, K. Nones, A. L. Johns, A. M. Patch, M. C. Gingras, D. K. Miller, A. N. Christ, T. J. C. Bruxner, M. C. Quinn, C. Nourse, L. C. Murtaugh, I. Harliwong, S. Idrisoglu, S. Manning, E. Nourbakhsh, S. Wani, L. Fink, O. Holmes, V. Chin, M. J. Anderson, S. Kazakoff, C. Leonard, F. Newell, N. Waddell, S. Wood, Q. Xu, P. J. Wilson, N. Cloonan, K. S. Kassahn, D. Taylor, K. Quek, A. Robertson, L. Pantano, L. Mincarelli, L. N. Sanchez, L. Evers, J. Wu, M. Pinese, M. J. Cowley, M. D. Jones, E. K. Colvin, A. M. Nagrial, E. S. Humphrey, L. A. Chantrill, A. Mawson, J. Humphris, A. Chou, M. Pajic, C. J. Scarlett, A. V. Pinho, M. Giry-Laterriere, I. Rooman, J. S. Samra, J. G. Kench, J. A. Lovell, N. D. Merrett, C. W. Toon, K. Epari, N. Q. Nguyen, A. Barbour, N. Zeps, K. Moran-Jones, N. B. Jamieson, J. S. Graham, F. Duthie, K. Oien, J. Hair, R. Grützmann, A. Maitra, C. A. Iacobuzio-Donahue, C. L. Wolfgang, R. A. Morgan, R. T. Lawlor, V. Corbo, C. Bassi, B. Rusev, P. Capelli, R. Salvia, G. Tortora, D. Mukhopadhyay, G. M. Petersen, D. M. Munzy, W. E. Fisher, S. A. Karim, J. R. Eshleman, R. H. Hruban, C. Pilarsky, J. P. Morton, O. J. Sansom, A. Scarpa, E. A. Musgrove, U. M. H. Bailey, O. Hofmann, R. L. Sutherland, D. A. Wheeler, A. J. Gill, R. A. Gibbs, J. V. Pearson, N. Waddell, A. V. Biankin and S. M. Grimmond (2016). “Genomic analyses identify molecular subtypes of pancreatic cancer.” Nature 531(7592): 47-52.
Batabyal, P., R. L. Haddad, J. S. Samra, S. Wickins, E. Sweeney and T. J. Hugh (2016). “Inguinal hernia repair with Parietex ProGrip mesh causes minimal discomfort and allows early return to normal activities.” American Journal of Surgery 211(1): 24-30.
Beier, A., I. Teichert, C. Krisp, D. A. Wolters and U. Kück (2016). “Catalytic subunit 1 of protein phosphatase 2A is a subunit of the STRIPAK complex and governs fungal sexual development.” mBio 7(3).
Blake, S. J., Z. Cheng, S. Atakaramians, S. Meikle, M. Lu, P. Vial and Z. Kuncic (2016). “In silico investigation of factors affecting the MV imaging performance of a novel water-equivalent EPID.” Physica Medica 32(12): 1819-1826.
Bogun, Y., L. Sioson, N. Watson, J. Pickett and A. Gill (2016). “False-positive EGFR Mutation-specific Immunohistochemistry in HER2-positive breast cancers: A potential diagnostic pitfall.” Applied Immunohistochemistry and Molecular Morphology 24(3): 227.
Boisen, S., C. Krägeloh, D. Shepherd, C. Ryan, J. Masters, S. Osborne, R. D. MacLeod, M. Gray and J. W. Keogh (2016). “A cross-sectional comparison of quality of life between physically active and underactive older men with prostate cancer.” Journal of Aging and Physical Activity 24(4): 642-648.
Booth, J. T., V. Caillet, N. Hardcastle, R. O’Brien, K. Szymura, C. Crasta, B. Harris, C. Haddad, T. Eade and P. J. Keall (2016). “The first patient treatment of electromagnetic-guided real time adaptive radiotherapy using MLC tracking for lung SABR.” Radiotherapy and Oncology 121(1): 19-25.
Bowyer, S., P. Prithviraj, P. Lorigan, J. Larkin, G. McArthur, V. Atkinson, M. Millward, M. Khou, S. Diem, S. Ramanujam, B. Kong, E. Liniker, A. Guminski, P. Parente, M. C. Andrews, S. Parakh, J. Cebon, G. V. Long, M. S. Carlino and O. Klein (2016). “Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.” British Journal of Cancer 114(10): 1084-1089.
Boyages, J., S. Kalfa, Y. Xu, L. Koelmeyer, H. Mackie, H. Viveros, L. Taksa and P. Gollan (2016). “Worse and worse off: the impact of lymphedema on work and career after breast cancer.” SpringerPlus 5(1).
Boyages, J., K. Stuart and C. Shah (2016). “Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.” JAMA oncology 2(3): 399-400.
Boyages, J., Y. Xu, S. Kalfa, L. Koelmeyer, B. Parkinson, H. Mackie, H. Viveros, P. Gollan and L. Taksa (2016). “Financial cost of lymphedema borne by women with breast cancer.” Psycho-Oncology.
Boyle, F. M., J. H. Dean, C. E. Young and A. J. Mutch (2016). “Why do people with chronic disease not contact consumer health organisations? A survey of general practice patients.” Primary Health Care Research and Development 17(4): 393-404.
Brennan, M. and N. Houssami (2016). “Discussing the benefits and harms of screening mammography.” Maturitas 92: 150-153.
Brennan, M. E. (2016). “The role of clinical breast examination in cancer screening for women at average risk: A mini review.” Maturitas 92: 61-63.
Brennan, M. E., P. Butow, A. J. Spillane and F. Boyle (2016). “Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning.” Asia-Pacific Journal of Clinical Oncology 12(2): e323-e331.
Brennan, M. E., K. Flitcroft, S. Warrier, K. Snook and A. J. Spillane (2016). “Immediate expander/implant breast reconstruction followed by post-mastectomy radiotherapy for breast cancer: Aesthetic, surgical, satisfaction and quality of life outcomes in women with high-risk breast cancer.” Breast 30: 59-65.
Brown, B., S. Egger, J. Young, A. B. Kneebone, A. J. Brooks, A. Dominello and M. Haines (2016). “Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists.” Journal of Medical Imaging and Radiation Oncology.
Brown, B., J. Young, A. B. Kneebone, A. J. Brooks, A. Dominello and M. Haines (2016). “Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: An Australian survey of urologists.” BJU International 117: 35-44.
Brown, K. M., J. S. Gundara and A. Mittal (2016). “Acute gastrointestinal manifestation of situs inversus abdominus.” Hernia: 1-3.
Bullock, M., Y. Ren, C. O’Neill, A. Gill, A. Aniss, M. Sywak, S. Sidhu, L. Delbridge, D. Learoyd, F. de Vathaire, B. G. Robinson and R. J. Clifton-Bligh (2016). “TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.” Clinical Endocrinology 85(2): 283-290.
Byrne, K., G. Hruby, A. Kneebone, D. Whalley, L. Guo, P. McCloud and T. Eade (2016). “Late Genitourinary Toxicity Outcomes in 300 Prostate Cancer Patients Treated With Dose-escalated Image-guided Intensity-modulated Radiotherapy.” Clinical Oncology.
Caine, H., D. Whalley, A. Kneebone, P. McCloud and T. Eade (2016). “Using individual patient anatomy to predict protocol compliance for prostate intensity-modulated radiotherapy.” Medical Dosimetry 41(1): 70-74.
Carlino, M. S., V. Vanella, C. Girgis, D. Giannarelli, A. Guminski, L. Festino, R. F. Kefford, A. M. Menzies, G. V. Long and P. A. Ascierto (2016). “Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series.” British Journal of Cancer.
Chan, D. L. H., D. Espinoza, J. Chan, A. Lee, W. Faisal, E. Segelov and N. Pavlakis (2016). “Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer.” Cochrane Database of Systematic Reviews 2016(12).
Chan, J. C. Y., D. L. Chan, C. I. Diakos, A. Engel, N. Pavlakis, A. Gill and S. J. Clarke (2016). “The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.” Annals of Surgery.
Charles, K. A., B. D. W. Harris, C. R. Haddad, S. J. Clarke, A. Guminski, M. Stevens, T. Dodds, A. J. Gill, M. Back, D. Veivers and T. Eade (2016). “Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.” BMC Cancer 16(1).
Chen, A. C., A. J. Martin, R. A. Dalziell, C. A. McKenzie, P. M. Lowe, J. M. Eris, R. A. Scolyer, H. M. Dhillon, J. L. Vardy, V. A. Bielski, G. M. Halliday and D. L. Damian (2016). “A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.” British Journal of Dermatology.
Chen, J., N. Zhang, C. Guo, F. Pan, X. Zhou, H. Suo, X. Zhao and E. M. Goldys (2016). “Site-Dependent Luminescence and Thermal Stability of Eu2+ Doped Fluorophosphate toward White LEDs for Plant Growth.” ACS Applied Materials and Interfaces 8(32): 20856-20864.
Cheng, Y. Y., C. M. Wright, M. B. Kirschner, M. Williams, K. H. Sarun, V. Sytnyk, I. Leshchynska, J. J. Edelman, M. P. Vallely, B. C. McCaughan, S. Klebe, N. van Zandwijk, R. C. Y. Lin and G. Reid (2016). “KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.” Molecular Cancer 15(1).
Chua, T. C., P. R. De Reuver, R. F. Staerkle, M. L. Neale, J. Arena, A. Mittal, S. T. Shanbhag, A. J. Gill and J. S. Samra (2016). “Transverse closure of mesenterico-portal vein after vein resection in pancreatoduodenectomy.” European Journal of Surgical Oncology 42(2): 211-218.
Chua, T. C., P. Gill, A. J. Gill and J. S. Samra (2016). “Ileocecal Intussusception Caused by an Appendiceal Neoplasm.” Journal of Gastrointestinal Surgery 20(4): 867-868.
Chua, T. C., A. Mittal, J. Arena, A. Sheen, A. J. Gill and J. S. Samra (2016). “Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma.” American Journal of Surgery.
Chua, T. C., W. Petrushnko, A. Mittal, A. J. Gill and J. S. Samra (2016). “Pancreatic Metastasectomy—an Analysis of Survival Outcomes and Prognostic Factors.” Journal of Gastrointestinal Surgery 20(6): 1188-1193.
Chua, T. C., T. X. Yang, A. J. Gill and J. S. Samra (2016). “Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions.” Annals of Surgical Oncology 23(2): 592-599.
Clement, S., W. Deng, E. Camilleri, B. C. Wilson and E. M. Goldys (2016). “X-ray induced singlet oxygen generation by nanoparticle-photosensitizer conjugates for photodynamic therapy: Determination of singlet oxygen quantum yield.” Scientific Reports 6.
Cole, A. J., T. Dwight, A. J. Gill, K. A. Dickson, Y. Zhu, A. Clarkson, G. B. Gard, J. Maidens, S. Valmadre, R. Clifton-Bligh and D. J. Marsh (2016). “Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.” Scientific Reports 6.
Colvill, E., J. Booth, S. Nill, M. Fast, J. Bedford, U. Oelfke, M. Nakamura, P. Poulsen, E. Worm, R. Hansen, T. Ravkilde, J. Scherman Rydhög, T. Pommer, P. Munck Af Rosenschold, S. Lang, M. Guckenberger, C. Groh, C. Herrmann, D. Verellen, K. Poels, L. Wang, M. Hadsell, T. Sothmann, O. Blanck and P. Keall (2016). “A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking.” Radiotherapy and Oncology 119(1): 159-165.
Crassini, K., Y. Shen, S. Mulligan and O. Giles Best (2016). “Modeling the chronic lymphocytic leukemia microenvironment in vitro.” Leukemia and Lymphoma: 1-14.
Czerniec, S. A., L. C. Ward and S. L. Kilbreath (2016). “Breast Cancer-Related Arm Lymphedema: Fluctuation over Six Months and the Effect of the Weather.” Lymphatic Research and Biology 14(3): 148-155.
Dawes, J. M., W. Z. W. Ismail, E. M. Goldys and D. W. Coutts (2016). Enhancing the performance of random lasers: Effects of Localised Surface Plasmons and Resonance Energy Transfer. PHOTOPTICS 2016 – Proceedings of the 4th International Conference on Photonics, Optics and Laser Technology.
De Paoli-Iseppi, R., P. A. Johansson, A. M. Menzies, K. R. Dias, G. M. Pupo, H. Kakavand, J. S. Wilmott, G. J. Mann, N. K. Hayward, M. E. Dinger, G. V. Long and R. A. Scolyer (2016). “Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: Implications for clinical decision making.” Pathology 48(3): 261-266.
de Reuver, P. R., J. Gundara, T. J. Hugh, J. S. Samra and A. Mittal (2016). “Intra-operative amylase in peri-pancreatic fluid independently predicts for pancreatic fistula post pancreaticoduodectomy.” HPB 18(7): 608-614.
De Reuver, P. R., S. Mehta, P. Gill, J. Andrici, L. D’Urso, A. Clarkson, A. Mittal, T. J. Hugh, J. S. Samra and A. J. Gill (2016). “Immunoregulatory forkhead box protein p3-positive lymphocytes are associated with overall survival in patients with pancreatic neuroendocrine tumors.” Journal of the American College of Surgeons 222(3): 281-287.
Deng, W., Z. Kautzka, W. Chen and E. M. Goldys (2016). “PLGA nanocomposites loaded with verteporfin and gold nanoparticles for enhanced photodynamic therapy of cancer cells.” RSC Advances 6(113): 112393-112402.
Dengate, A. L., M. C. Morel-Kopp, J. A. Beatty, V. Barrs, J. A. Braddock, R. K. Churcher, B. J. Wilson and C. M. Ward (2016). “Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay.” Journal of Veterinary Emergency and Critical Care 26(3): 446-452.
Dickson, K. A., A. J. Cole, A. J. Gill, A. Clarkson, G. B. Gard, A. Chou, C. J. Kennedy, B. R. Henderson, S. Fereday, N. Traficante, K. Alsop, D. D. Bowtell, A. de Fazio, R. Clifton-Bligh and D. J. Marshs (2016). “The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.” Human Molecular Genetics 25(24): 5460-5471.
Domanova, W., J. Krycer, R. Chaudhuri, P. Yang, F. Vafaee, D. Fazakerley, S. Humphrey, D. James and Z. Kuncic (2016). “Unraveling kinase activation dynamics using kinase-substrate relationships from temporal Large-Scale phosphoproteomics studies.” PLoS ONE 11(6).
Dong, S. T., P. N. Butow, M. Agar, M. R. Lovell, F. Boyle, M. Stockler, B. C. Forster and A. Tong (2016). “Clinicians’ Perspectives on Managing Symptom Clusters in Advanced Cancer: A Semistructured Interview Study.” Journal of Pain and Symptom Management.
Dong, S. T., P. N. Butow, A. Tong, M. Agar, F. Boyle, B. C. Forster, M. Stockler and M. R. Lovell (2016). “Patients’ experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study.” Supportive Care in Cancer 24(3): 1373-1386.
Dong, S. T., D. S. J. Costa, P. N. Butow, M. R. Lovell, M. Agar, G. Velikova, P. Teckle, A. Tong, N. C. Tebbutt, S. J. Clarke, K. Van Der Hoek, M. T. King and P. M. Fayers (2016). “Symptom clusters in advanced cancer patients: An empirical comparison of statistical methods and the impact on quality of life.” Journal of Pain and Symptom Management 51(1): 88-98.
Duggleby, W., C. A. Robinson, S. Kaasalainen, B. Pesut, C. Nekolaichuk, R. MacLeod, N. C. Keating, A. Santos Salas, L. K. Hallstrom, K. D. Fraser, A. Williams, K. Struthers-Montford and J. Swindle (2016). “Developing Navigation Competencies to Care for Older Rural Adults with Advanced Illness.” Canadian Journal on Aging: 1-9.
Dummer, R., A. Guminski, R. Gutzmer, L. Dirix, K. D. Lewis, P. Combemale, R. M. Herd, M. Kaatz, C. Loquai, A. J. Stratigos, H. J. Schulze, R. Plummer, S. Gogov, C. Pallaud, T. Yi, M. Mone, A. L. S. Chang, F. Cornélis, R. Kudchadkar, U. Trefzer, J. T. Lear, D. Sellami and M. R. Migden (2016). “The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.” Journal of the American Academy of Dermatology 75(1): 113-125.e115.
Dylke, E. S., G. P. Schembri, D. L. Bailey, E. Bailey, L. C. Ward, K. Refshauge, J. Beith, D. Black and S. L. Kilbreath (2016). “Diagnosis of upper limb lymphedema: development of an evidence-based approach.” Acta Oncologica: 1-7.
Engel, A. (2016). “Laparascopic assisted colonscopic polypectomy: a truly multidisciplinary treatment and research platform.” Colorectal Disease 18(11): 1029-1030.
Eslick, E. M., D. L. Bailey, B. Harris, J. Kipritidis, M. Stevens, B. T. Li, E. Bailey, D. Gradinscak, S. Pollock, C. Htun, R. Turner, T. Eade, A. Aslani, G. Snowdon and P. J. Keall (2016). “Measurement of preoperative lobar lung function with computed tomography ventilation imaging: Progress towards rapid stratification of lung cancer lobectomy patients with abnormal lung function.” European Journal of Cardio-thoracic Surgery 49(4): 1075-1082.
Farnsworth, A. (2016). “Cervical cancer screening in Australia: Past and present.” Cancer Cytopathology 124(4): 231-234.
Farnsworth, A. (2016). “Self-sampling HPV testing versus mainstream cervical screening and HPV testing.” Medical Journal of Australia 204(5): 171-171.e171.
Farrokhzadi, L., H. M. Dhillon, C. Goumas, J. M. Young and A. E. Cust (2016). “Physical Activity Correlates, Barriers, and Preferences for Women with Gynecological Cancer.” International Journal of Gynecological Cancer 26(8): 1530-1537.
Feain, I., C. C. Shieh, P. White, R. O’Brien, S. Fisher, W. Counter, P. Lazarakis, D. Stewart, S. Downes, M. Jackson, S. Baxi, B. Whelan, K. Makhija, C. Y. Huang, M. Barton and P. Keall (2016). “Functional imaging equivalence and proof of concept for image-guided adaptive radiotherapy with fixed gantry and rotating couch.” Advances in Radiation Oncology 1(4): 365-372.
Field, K. M., M. A. Rosenthal, M. Khasraw, K. Sawkins and A. K. Nowak (2016). “Evolving management of low grade glioma: No consensus amongst treating clinicians.” Journal of Clinical Neuroscience 23: 81-87.
Flitcroft, K., M. Brennan, D. Costa and A. Spillane (2016). “Documenting patterns of breast reconstruction in Australia: The national picture.” Breast 30: 47-53.
Flitcroft, K., M. Brennan, D. Costa, A. Wong, K. Snook and A. Spillane (2016). “An evaluation of factors affecting preference for immediate, delayed or no breast reconstruction in women with high-risk breast cancer.” Psycho-Oncology.
Flynn, A., T. Dwight, J. Harris, D. Benn, L. Zhou, A. Hogg, D. Catchpoole, P. James, E. L. Duncan, A. Trainer, A. J. Gill, R. Clifton-Bligh, R. J. Hicks and R. W. Tothill (2016). “Pheo-type: A diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma.” Journal of Clinical Endocrinology and Metabolism 101(4): 1034-1043.
Fong, K. M. and N. van Zandwijk (2016). “Update in lung cancer: Epilogue to a modern review series.” Respirology.
Forster, B. C., H. Proskurin, B. Kelly, M. R. Lovell, R. Ilchef and J. M. Clayton (2016). “Psychiatry trainees’ views and educational needs regarding the care of patients with a life-limiting illness.” Palliative and Supportive Care: 1-11.
Fox, P., R. L. Balleine, C. Lee, B. Gao, B. Balakrishnar, A. M. Menzies, S. H. Yeap, S. S. Ali, V. Gebski, P. Provan, S. Coulter, C. Liddle, R. Hui, R. Kefford, J. Lynch, M. Wong, N. Wilcken and H. Gurney (2016). “Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring – The TADE study.” Clinical Cancer Research 22(13): 3164-3171.
Franklin, A. E., M. R. Lovell and F. Boyle (2016). “A Case of Opioid Toxicity on Conversion From Extended-Release Oxycodone and Naloxone to Extended-Release Oxycodone in a Patient With Liver Dysfunction.” Journal of Pain and Symptom Management.
Fraser, S., C. Go, A. Aniss, S. Sidhu, L. Delbridge, D. Learoyd, R. Clifton-Bligh, L. Tacon, V. Tsang, B. Robinson, A. J. Gill and M. Sywak (2016). “BRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.” World Journal of Surgery 40(7): 1618-1624.
Fraser, S., N. Zaidi, O. Norlén, A. Glover, S. Kruijff, M. Sywak, L. Delbridge and S. B. Sidhu (2016). “Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer.” Annals of Surgical Oncology: 1-6.
Friedman, K., A. S. Brodsky, S. Lu, S. Wood, A. J. Gill, K. Lombardo, D. Yang and M. B. Resnick (2016). “Medullary carcinoma of the colon: A distinct morphology reveals a distinctive immunoregulatory microenvironment.” Modern Pathology 29(5): 528-541.
Gallinger, B., H. Druker, A. J. Gill, J. D. Wasserman and R. H. Kim (2016). “The adrenal gland: An evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers.” Diagnostic Histopathology 22(3): 108-122.
Galougahi, K. K., C. C. Liu, A. Garcia, C. Gentile, N. A. Fry, E. J. Hamilton, C. L. Hawkins and G. A. Figtree (2016). “b3 adrenergic stimulation restores nitric oxide/redox balance and enhances endothelial function in hyperglycemia.” Journal of the American Heart Association 5(2).
Garber, S. T., Y. Hashimoto, S. P. Weathers, J. Xiu, Z. Gatalica, R. G. W. Verhaak, S. Zhou, G. N. Fuller, M. Khasraw, J. De Groot, S. K. Reddy, D. Spetzler and A. B. Heimberger (2016). “Immune checkpoint blockade as a potential therapeutic target: Surveying CNS malignancies.” Neuro-Oncology 18(10): 1357-1366.
Gifford, G. K., A. J. Gill and W. S. Stevenson (2016). “Molecular subtyping of diffuse large B-cell lymphoma: Update on biology, diagnosis and emerging platforms for practising pathologists.” Pathology 48(1): 5-16.
Gingras, M. C., K. R. Covington, D. K. Chang, L. A. Donehower, A. J. Gill, M. M. Ittmann, C. J. Creighton, A. L. Johns, E. Shinbrot, N. Dewal, W. E. Fisher, C. Pilarsky, R. Grützmann, M. J. Overman, N. B. Jamieson, G. Van Buren, J. Drummond, K. Walker, O. A. Hampton, L. Xi, D. M. Muzny, H. Doddapaneni, S. L. Lee, M. Bellair, J. Hu, Y. Han, H. H. Dinh, M. Dahdouli, J. S. Samra, P. Bailey, N. Waddell, J. V. Pearson, I. Harliwong, H. Wang, D. Aust, K. A. Oien, R. H. Hruban, S. E. Hodges, A. McElhany, C. Saengboonmee, F. R. Duthie, S. M. Grimmond, A. V. Biankin, D. A. Wheeler, R. A. Gibbs, M. D. Jones, A. Mawson, C. J. Scarlett, M. A. L. Brancato, S. J. Rowe, S. H. Simpson, M. Smith Martyn, M. T. Thomas, L. A. Chantrill, V. T. Chin, C. Angela, M. J. Cowley, J. L. Humphris, S. Mead, A. M. Nagrial, M. Pajic, J. Pettit, M. Pinese, I. Rooman, J. Wu, J. Tao, R. DiPietro, C. Watson, A. Steinmann, H. C. Lee, R. Wong, A. V. Pinho, M. Giry-Laterriere, R. J. Daly, E. A. Musgrove, R. L. Sutherland, K. S. Kassahn, D. K. Miller, P. J. Wilson, A. M. Patch, S. Song, S. Idrisoglu, C. Nourse, E. Nourbakhsh, S. Manning, S. Wani, M. Gongora, M. Anderson, O. Holmes, C. Leonard, D. Taylor, S. Wood, C. Xu, K. Nones, L. J. Fink, A. Christ, T. Bruxner, N. Cloonan, F. Newell, M. Quinn, S. Nagaraj, S. Kazakoff, N. Waddell, K. Krisnan, Queelly, D. Wood, N. Pavlakis, A. Guminski, C. Toon, R. Asghari, N. D. Merrett, D. Pavey, A. Das, P. H. Cosman, K. Ismail, C. O’Connnor, V. W. Lam, D. McLeod, H. C. Pleass, A. Richardson, V. James, J. G. Kench, C. L. Cooper, D. Joseph, C. Sandroussi, M. Crawford, J. Gallagher, M. Texler, C. Forest, A. Laycock, K. P. Epari, M. Ballal, D. R. Fletcher, S. Mukhedkar, N. A. Spry, B. DeBoer, M. Chai, N. Zeps, M. Beilin, K. Feeney, N. Q. Nguyen, A. R. Ruszkiewicz, C. Worthley, C. P. Tan, T. Debrencini, J. Chen, M. E. Brooke-Smith, V. Papangelis, H. Tang, A. P. Barbour, A. D. Clouston, P. Martin, T. J. O’Rourke, A. Chiang, J. W. Fawcett, K. Slater, S. Yeung, M. Hatzifotis, P. Hodgkinson, C. Christophi, M. Nikfarjam, A. Mountain, J. R. Eshleman, A. Maitra, C. A. Iacobuzio-Donahue, R. D. Schulick, C. L. Wolfgang, R. A. Morgan, M. Hodgin, A. Scarpa, R. T. Lawlor, S. Beghelli, V. Corbo, M. Scardoni, C. Bassi, M. A. Tempero, G. Glasgow and J. S. Graham (2016). “Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.” Cell Reports 14(4): 907-919.
Glastras, S. J., H. Chen, R. T. McGrath, A. A. Zaky, A. J. Gill, C. A. Pollock and S. Saad (2016). “Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity.” Scientific Reports 6.
Gonzales, N. M., V. M. Howell and C. M. Smith (2016). “29th International Mammalian Genome Conference meeting report.” Mammalian Genome 27(5-6): 169-178.
Gosnell, M. E., A. G. Anwer, S. B. Mahbub, S. Menon Perinchery, D. W. Inglis, P. P. Adhikary, J. A. Jazayeri, M. A. Cahill, S. Saad, C. A. Pollock, M. L. Sutton-Mcdowall, J. G. Thompson and E. M. Goldys (2016). “Quantitative non-invasive cell characterisation and discrimination based on multispectral autofluorescence features.” Scientific Reports 6.
Gundara, J., J. Samra and A. Mittal (2016). “Pancreatic ductal adenocarcinoma Optimal patient Management.” Medicine Today 17(4): 14-20.
Gzell, C. E., H. R. Wheeler, P. McCloud, M. Kastelan and M. Back (2016). “Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.” Journal of Neuro-Oncology 128(1): 67-74.
Hadden, W. J., P. R. de Reuver, K. Brown, A. Mittal, J. S. Samra and T. J. Hugh (2016). “Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes.” HPB 18(3): 209-220.
Halkett, G. K. B., E. A. Lobb, T. Shaw, M. M. Sinclair, L. Miller, E. Hovey and A. K. Nowak (2016). “Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma.” Supportive Care in Cancer: 1-7.
Harrison, W. J., J. Andrici, F. Maclean, R. Madadi-Ghahan, M. Farzin, L. Sioson, C. W. Toon, A. Clarkson, N. Watson, J. Pickett, M. Field, A. Crook, K. Tucker, A. Goodwin, L. Anderson, B. Srinivasan, P. Grossmann, P. Martinek, O. Ondič, O. Hes, K. Trpkov, R. J. Clifton-Bligh, T. Dwight and A. J. Gill (2016). “Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings.” American Journal of Surgical Pathology 40(5): 599-607.
Hassan, N., J. T. Zhao and S. B. Sidhu (2016). “The role of microRNAs in the pathophysiology of adrenal tumors.” Molecular and Cellular Endocrinology.
Haydock, M. D., A. Mittal, C. F. Wilkes, D. H. Lim, E. Broadbent and J. A. Windsor (2016). “Interaction between objective performance measures and subjective user perceptions in the evaluation of medical devices: A case study.” International Journal of Technology Assessment in Health Care 31(5): 297-303.
Haydu, L. E., J. T. Stollman, R. A. Scolyer, A. J. Spillane, M. J. Quinn, R. P. M. Saw, K. F. Shannon, J. R. Stretch, J. J. Bonenkamp and J. F. Thompson (2016). “Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1–2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.” Annals of Surgical Oncology 23(4): 1071-1081.
Hayes, S. A., S. Haefliger, B. Harris, N. Pavlakis, S. J. Clarke, M. P. Molloy and V. M. Howell (2016). “Exhaled breath condensate for lung cancer protein analysis: A review of methods and biomarkers.” Journal of Breath Research 10(3).
Hersch, J., A. Barratt, J. Jansen, L. Irwig, K. McGeechan, G. Jacklyn, H. Thornton, H. Dhillon, N. Houssami and K. McCaffery (2016). “The importance of enabling informed decision making for women considering breast cancer screening.” Journal of Medical Screening 23(1): 55.
Hoda, M. A., Y. Dong, A. Rozsas, T. Klikovits, V. Laszlo, B. Ghanim, P. Stockhammer, J. Ozsvar, M. Jakopovic, M. Samarzija, L. Brcic, M. Bendek, I. Szirtes, G. Reid, M. B. Kirschner, S. C. Kao, I. Opitz, W. Weder, T. Frauenfelder, T. D. L. Nguyen-Kim, C. Aigner, W. Klepetko, N. Van Zandwijk, W. Berger, B. Dome, M. Grusch and B. Hegedus (2016). “Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma – A multi-institutional study.” European Journal of Cancer 63: 64-73.
Hodges, T. R., S. D. Ferguson, H. G. Caruso, G. Kohanbash, S. Zhou, T. F. Cloughesy, M. S. Berger, G. H. Poste, M. Khasraw, S. Ba, T. Jiang, T. Mikkelson, W. K. A. Yung, J. F. de Groot, H. Fine, L. C. Cantley, I. K. Mellinghoff, D. A. Mitchell, H. Okada and A. B. Heimberger (2016). “Prioritization schema for immunotherapy clinical trials in glioblastoma.” OncoImmunology.
Hruby, G., T. Eade, A. Kneebone, L. Emmett, L. Guo, B. Ho, E. Hsiao, G. Schembri, J. Hunter and C. Kwong (2016). “Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.” Radiotherapy and Oncology.
Huang, C., Y. Zhang, D. J. Kelly, C. Y. R. Tan, A. Gill, D. Cheng, F. Braet, J. S. Park, C. M. Sue, C. A. Pollock and X. M. Chen (2016). “Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.” Scientific Reports 6.
Huang, P. Y., S. MacTier, N. Armacki, O. Giles Best, L. Belov, K. L. Kaufman, D. Pascovici, S. P. Mulligan and R. I. Christopherson (2016). “Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.” Leukemia and Lymphoma 57(5): 1033-1043.
Huang, Y., T. C. Chua, G. J. Maddern and J. S. Samra (2016). “Robotic cholecystectomy versus conventional laparoscopic cholecystectomy: A meta-analysis.” Surgery (United States).
Huang, Y. T. T., J. Park, S. Chong, T. J. Hugh, W. L. Ng and M. Lin (2016). “The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.” Asia-Pacific Journal of Clinical Oncology.
Hudson, A. L. and E. K. Colvin (2016). “Transgenic mouse models of SV40-induced cancer.” ILAR Journal 57(1): 44-54.
Ioannidis, J. and F. X. Donadeu (2016). “Circulating microRNA profiles during the bovine oestrous cycle.” PLoS ONE 11(6).
Ismail, W. Z. W., E. M. Goldys and J. M. Dawes (2016). Fluorescence resonance energy transfer (FRET) in random dye lasers. 2015 11th Conference on Lasers and Electro-Optics Pacific Rim, CLEO-PR 2015.
Ismail, W. Z. W., G. Liu, K. Zhang, E. M. Goldys and J. M. Dawes (2016). “Dopamine sensing and measurement using threshold and spectral measurements in random lasers.” Optics Express 24(2): A85-A91.
Jamieson, C., K. M. Mills, C. Lui, C. Semaan, M. P. Molloy, M. Sharma, J. K. Forwood and B. R. Henderson (2016). “Characterization of a beta-catenin nuclear localization defect in MCF-7 breast cancer cells.” Experimental Cell Research 341(2): 196-206.
Jin, F., A. E. Grulich, I. M. Poynten, R. J. Hillman, D. J. Templeton, C. L. Law, A. Farnsworth, S. M. Garland, C. K. Fairley and J. M. Roberts (2016). “The performance of anal cytology as a screening test for anal HSILs in homosexual men.” Cancer Cytopathology.
Jin, F., A. E. Grulich, I. M. Poynten, R. J. Hillman, D. J. Templeton, C. L. H. Law, A. Farnsworth, S. M. Garland, C. K. Fairley, J. M. Roberts and S. S. T. and on behalf of the (2016). “The performance of anal cytology as a screening test for anal HSILs in homosexual men.” Cancer Cytopathology 124(6): 415-424.
Johnson, D. B., R. J. Sullivan, P. A. Ott, M. S. Carlino, N. I. Khushalani, F. Ye, A. Guminski, I. Puzanov, D. P. Lawrence, E. I. Buchbinder, T. Mudigonda, K. Spencer, C. Bender, J. Lee, H. L. Kaufman, A. M. Menzies, J. C. Hassel, J. M. Mehnert, J. A. Sosman, G. V. Long and J. I. Clark (2016). “Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.” JAMA oncology 2(2): 234-240.
Johnson, S., J. Clayton, P. N. Butow, W. Silvester, K. Detering, J. Hall, B. E. Kiely, J. Cebon, S. Clarke, M. L. Bell, M. Stockler, P. Beale and M. H. N. Tattersall (2016). “Advance care planning in patients with incurable cancer: Study protocol for a randomised controlled trial.” BMJ Open 6(12).
Julovi, S. M., A. Xue, T. N. Thanh Le, A. J. Gill, J. C. Bulanadi, M. Patel, L. J. Waddington, K. A. Rye, M. J. Moghaddam and R. C. Smith (2016). “Apolipoprotein A-II plus lipid emulsion enhance cell growth via SR-B1 and target pancreatic cancer in vitro and in vivo.” PLoS ONE 11(3).
Kanthan, G. L., E. Hsiao, A. Kneebone, T. Eade and G. P. Schembri (2016). “Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT.” Clinical Nuclear Medicine.
Kanthan, G. L., G. P. Schembri, J. Samra, P. Roach and E. Hsiao (2016). “Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan.” Clinical Nuclear Medicine.
Kao, S. C., M. B. Kirschner, W. A. Cooper, T. Tran, S. Burgers, C. Wright, T. Korse, D. Van Den Broek, J. Edelman, M. Vallely, B. McCaughan, N. Pavlakis, S. Clarke, M. P. Molloy, N. Van Zandwijk and G. Reid (2016). “A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.” British Journal of Cancer 114(5): 524-531.
Kaur, A., M. R. Webster, K. Marchbank, R. Behera, A. Ndoye, C. H. Kugel, V. M. Dang, J. Appleton, M. P. O’Connell, P. Cheng, A. A. Valiga, R. Morissette, N. B. McDonnell, L. Ferrucci, A. V. Kossenkov, K. Meeth, H. Y. Tang, X. Yin, W. H. Wood, E. Lehrmann, K. G. Becker, K. T. Flaherty, D. T. Frederick, J. A. Wargo, Z. A. Cooper, M. T. Tetzlaff, C. Hudgens, K. M. Aird, R. Zhang, X. Xu, Q. Liu, E. Bartlett, G. Karakousis, Z. Eroglu, R. S. Lo, M. Chan, A. M. Menzies, G. V. Long, D. B. Johnson, J. Sosman, B. Schilling, D. Schadendorf, D. W. Speicher, M. Bosenberg, A. Ribas and A. T. Weeraratna (2016). “Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.” Nature.
Kaur, A., M. R. Webster, K. Marchbank, R. Behera, A. Ndoye, C. H. Kugel, V. M. Dang, J. Appleton, M. P. O’Connell, P. Cheng, A. A. Valiga, R. Morissette, N. B. McDonnell, L. Ferrucci, A. V. Kossenkov, K. Meeth, H. Y. Tang, X. Yin, W. H. Wood, E. Lehrmann, K. G. Becker, K. T. Flaherty, D. T. Frederick, J. A. Wargo, Z. A. Cooper, M. T. Tetzlaff, C. Hudgens, K. M. Aird, R. Zhang, X. Xu, Q. Liu, E. Bartlett, G. Karakousis, Z. Eroglu, R. S. Lo, M. Chan, A. M. Menzies, G. V. Long, D. B. Johnson, J. Sosman, B. Schilling, D. Schadendorf, D. W. Speicher, M. Bosenberg, A. Ribas and A. T. Weeraratna (2016). “SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.” Nature 532(7598): 250-254.
Keall, P. J., J. A. Ng, P. Juneja, R. T. O’Brien, C. Y. Huang, E. Colvill, V. Caillet, E. Simpson, P. R. Poulsen, A. Kneebone, T. Eade and J. T. Booth (2016). “Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.” International Journal of Radiation Oncology Biology Physics 94(5): 1015-1021.
Kemp-Casey, A., E. E. Roughead, C. Saunders, F. Boyle, M. Bulsara and D. B. Preen (2016). “Switching between endocrine therapies for primary breast cancer: Frequency and timing in Australian clinical practice.” Asia-Pacific Journal of Clinical Oncology.
Khasraw, M., S. Ananda and M. Michael (2016). “Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.” Expert Review of Anticancer Therapy 16(4): 391-401.
Khasraw, M., A. Lee, S. McCowatt, Z. Kerestes, M. E. Buyse, M. Back, G. Kichenadasse, S. Ackland and H. Wheeler (2016). “Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.” Journal of Neuro-Oncology 128(1): 163-171.
Kilbreath, S. L., K. M. Refshauge, J. M. Beith, L. C. Ward, O. A. Ung, E. S. Dylke, J. R. French, J. Yee, L. Koelmeyer and K. Gaitatzis (2016). “Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.” Breast 28: 29-36.
Kim, J. H., T. Sun, A. R. Alcheikh, Z. Kuncic, J. Nuyts and R. Fulton (2016). “Correction for human head motion in helical x-ray CT.” Physics in Medicine and Biology 61(4): 1416-1438.
Kiyota, N., M. Schlumberger, K. Muro, Y. Ando, S. Takahashi, Y. Kawai, L. Wirth, B. Robinson, S. Sherman, T. Suzuki, K. Fujino, A. Gupta, S. Hayato and M. Tahara (2016). “Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer.” Cancer Science 106(12): 1714-1721.
Kong, B. Y., A. M. Menzies, C. A. B. Saunders, E. Liniker, S. Ramanujam, A. Guminski, R. F. Kefford, G. V. Long and M. S. Carlino (2016). “Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.” Pigment Cell and Melanoma Research 29(5): 572-577.
Lane, R. J., N. Y. Khin, C. M. Rogan, J. Magnussen, N. Pavlakis, D. M. Lane and S. Clarke (2016). “Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study.” Annals of Surgical Oncology: 1-10.
Lee, D., P. B. Greer, J. Ludbrook, J. Arm, P. Hunter, S. Pollock, K. Makhija, R. T. O’Brien, T. Kim and P. Keall (2016). “Audiovisual Biofeedback Improves Cine-Magnetic Resonance Imaging Measured Lung Tumor Motion Consistency.” International Journal of Radiation Oncology Biology Physics 94(3): 628-636.
Lee, D., P. B. Greer, S. Pollock, T. Kim and P. Keall (2016). “Quantifying the accuracy of the tumor motion and area as a function of acceleration factor for the simulation of the dynamic keyhole magnetic resonance imaging method.” Medical Physics 43(5): 2639-2648.
Lee, J., S. Fraser, A. Glover and S. Sidhu (2016). “Prospective evaluation of the utility of routine neuromonitoring for an established thyroid surgical practice.” ANZ Journal of Surgery.
Lester, A., R. Rapkins, S. Nixdorf, M. Khasraw and K. McDonald (2016). “Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?” Clinical and Translational Oncology: 1-6.
Lewis, S., K. Willis, J. Yee and S. Kilbreath (2016). “Living Well? Strategies Used by Women Living with Metastatic Breast Cancer.” Qualitative Health Research 26(9): 1167-1179.
Li, B. T., T. A. Barnes, D. L. Chan, J. Naidoo, A. Lee, M. Khasraw, G. M. Marx, M. G. Kris, S. J. Clarke, A. Drilon, C. M. Rudin and N. Pavlakis (2016). “The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.” Lung Cancer 102: 21-27.
Li, J., O. G. Best, S. P. Mulligan and S. L. Fernando (2016). “Serum from a subset of patients with chronic lymphocytic leukemia and large local reactions to mosquito bites induces upregulation of CD63 surface expression on basophils in atopic donors.” Leukemia and Lymphoma: 1-4.
Liang, R., B. Meiser, S. Smith, N. A. Kasparian, C. R. Lewis, M. Chin, G. V. Long, R. Ward, A. M. Menzies, J. N. Harris-Wai and R. Kaur (2016). “Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: A qualitative study.” European Journal of Cancer Care.
Lim, E., J. L. Vardy, B. Oh and H. M. Dhillon (2016). “Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: A scoping study.” Asia-Pacific Journal of Clinical Oncology.
Lin, L. L., C. C. Huang, C. L. Wu, M. T. Wu, W. M. Hsu and J. H. Chuang (2016). “Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.” Laboratory Investigation 96(7): 719-730.
Liniker, E., A. M. Menzies, B. Y. Kong, A. Cooper, S. Ramanujam, S. Lo, R. F. Kefford, G. B. Fogarty, A. Guminski, T. W. Wang, M. S. Carlino, A. Hong and G. V. Long (2016). “Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma.” OncoImmunology.
Lippey, J., A. Spillane and C. Saunders (2016). “Not all ductal carcinoma in situ is created equal: can we avoid surgery for low-risk ductal carcinoma in situ?” ANZ Journal of Surgery 86(11): 859-860.
Liu, D., X. Xu, Y. Du, X. Qin, Y. Zhang, C. Ma, S. Wen, W. Ren, E. M. Goldys, J. A. Piper, S. Dou, X. Liu and D. Jin (2016). “Three-dimensional controlled growth of monodisperse sub-50 nm heterogeneous nanocrystals.” Nature Communications 7.
Liu, D., X. Xu, F. Wang, J. Zhou, C. Mi, L. Zhang, Y. Lu, C. Ma, E. Goldys, J. Lin and D. Jin (2016). “Emission stability and reversibility of upconversion nanocrystals.” Journal of Materials Chemistry C 4(39): 9227-9234.
Liu, G., M. Qi, M. R. Hutchinson, G. Yang and E. M. Goldys (2016). “Recent advances in cytokine detection by immunosensing.” Biosensors and Bioelectronics 79: 810-821.
Liu, G., M. Qi, Y. Zhang, C. Cao and E. M. Goldys (2016). “Nanocomposites of gold nanoparticles and graphene oxide towards an stable label-free electrochemical immunosensor for detection of cardiac marker troponin-I.” Analytica Chimica Acta 909: 1-8.
Lodewijk, L., W. P. Kluijfhout, J. W. Kist, I. Stegeman, J. T. M. Plukker, E. J. Nieveen van Dijkum, H. J. Bonjer, N. D. Bouvy, A. Schepers, J. H. W. de Wilt, R. T. Netea-Maier, J. A. van der Hage, J. W. A. Burger, G. Ho, W. S. Lee, W. T. Shen, A. Aronova, R. Zarnegar, C. Benay, E. J. Mitmaker, M. S. Sywak, A. M. Aniss, S. Kruijff, B. James, R. H. Grogan, L. Brunaud, G. Hoch, C. Pandolfi, D. T. Ruan, M. D. Jones, M. A. Guerrero, G. D. Valk, I. H. M. Borel Rinkes and M. R. Vriens (2016). “Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cm.” Langenbeck’s Archives of Surgery 401(3): 365-373.
Lyle, M., L. E. Haydu, A. M. Menzies, J. F. Thompson, R. P. M. Saw, A. J. Spillane, R. F. Kefford, G. J. Mann, W. A. Cooper, B. Yu, R. A. Scolyer, S. A. O’Toole and G. V. Long (2016). “The molecular profile of metastatic melanoma in Australia.” Pathology 48(2): 188-193.
MacDiarmid, J. A., V. Langova, D. Bailey, S. T. Pattison, S. L. Pattison, N. Christensen, L. R. Armstrong, V. N. Brahmbhatt, K. Smolarczyk, M. T. Harrison, M. Costa, N. B. Mugridge, I. Sedliarou, N. A. Grimes, D. L. Kiss, B. Stillman, C. L. Hann, G. L. Gallia, R. M. Graham and H. Brahmbhatt (2016). “Targeted doxorubicin delivery to brain tumors via minicells: Proof of principle using dogs with spontaneously occurring tumors as a model.” PLoS ONE 11(4).
MacKenzie Ross, A. D., L. E. Haydu, M. J. Quinn, R. P. M. Saw, K. F. Shannon, A. J. Spillane, J. R. Stretch, R. A. Scolyer and J. F. Thompson (2016). “The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study.” Annals of Surgical Oncology 23(4): 1082-1089.
MacLeod, R., J. Crandall, D. Wilson and P. Austin (2016). “Death anxiety among New Zealanders: the predictive role of gender and marital status.” Mental Health, Religion and Culture 19(4): 339-349.
Madore, J., D. Strbenac, R. Vilain, A. M. Menzies, J. Y. H. Yang, J. F. Thompson, G. V. Long, G. J. Mann, R. A. Scolyer and J. S. Wilmott (2016). “PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.” Clinical Cancer Research 22(15): 3915-3923.
Malalasekera, A., C. S. Y. Tan, V. Phan, P. Y. Yip, J. Vardy, S. Clarke and S. Kao (2016). “Eastern Cooperative Oncology Group score: Agreement between non-small-cell lung cancer patients and their oncologists and clinical implications.” Cancer Treatment Communications 5: 17-21.
Margaret Roberts, J., F. Jin, D. Ekman, M. Kay Adams, R. Lindsay McDonald, J. Kathleen Thurloe, A. Richards, I. Mary Poynten, C. Law, C. Kincaid Fairley, R. John Hillman, S. N. Tabrizi, A. Marie Cornall, D. James Templeton, S. Marie Garland, A. Edwin Grulich and A. Farnsworth (2016). “Is there a role for the thinprep imaging system in reporting anal cytology?” Diagnostic Cytopathology 44(5): 384-388.
Marsh, D. J. and C. Eng (2016). “Lessons learnt from outstanding mid-career women in endocrine cancer research.” Endocrine-Related Cancer 23(11): E5-E7.
Martínez-Aguilar, J., R. Clifton-Bligh and M. P. Molloy (2016). “Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy.” Scientific Reports 6.
McCaffery, K. J., S. Morony, D. M. Muscat, S. K. Smith, H. L. Shepherd, H. M. Dhillon, A. Hayen, K. Luxford, W. Meshreky, J. Comings and D. Nutbeam (2016). “Evaluation of an Australian health literacy training program for socially disadvantaged adults attending basic education classes: Study protocol for a cluster randomised controlled trial.” BMC Public Health 16(1).
McGrath, R. T., V. A. Preda, P. Clifton-Bligh, B. Robinson, M. Sywak, L. Delbridge, P. Ward, R. J. Clifton-Bligh and D. L. Learoyd (2016). “Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies A large (Australian) cohort study in differentiated thyroid cancer.” Clinical Endocrinology 84(2): 271-277.
McKelvey, K. J., V. M. Yenson, A. W. Ashton, J. M. Morris and S. A. McCracken (2016). “Embryonic/fetal mortality and intrauterine growth restriction is not exclusive to the CBA/J sub-strain in the CBA × DBA model.” Scientific Reports 6.
McNamara, A. L., W. W. Y. Kam, N. Scales, S. J. McMahon, J. W. Bennett, H. L. Byrne, J. Schuemann, H. Paganetti, R. Banati and Z. Kuncic (2016). “Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol.” Physics in Medicine and Biology 61(16): 5993-6010.
McSpedden, M., B. Mullan, L. Sharpe, L. J. Breen and E. A. Lobb (2016). “The presence and predictors of complicated grief symptoms in perinatally bereaved mothers from a bereavement support organization.” Death Studies: 1-6.
Menzies, A. M. and G. V. Long (2016). “Recent Developments in Melanoma Therapy.” JAMA oncology 2(10): 1259-1260.
Molano, M., S. N. Tabrizi, S. M. Garland, J. M. Roberts, D. A. MacHalek, S. Phillips, D. Chandler, R. J. Hillman, A. E. Grulich, F. Jin, I. M. Poynten, D. J. Templeton, A. M. Cornall, D. Templeton, K. McCaffery, K. Howard, A. Farnsworth, K. Fairley, G. Prestage, A. Carr, W. Tong, C. Law, B. Acraman, L. Crampton, L. Feeney, E. Fraissard, M. Law, P. McGrath, R. Mellor, R. Norris, M. O’Dwyer, S. Pendlebury, K. Petoumenos, A. Richards, L. Schema, D. Seeds, E. Segelov, J. Thurloe and R. Varma (2016). “CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker.” PLoS ONE 11(8).
Moloney, N., J. M. W. Sung, S. Kilbreath and E. Dylke (2016). “Prevalence and risk factors associated with pain 21 months following surgery for breast cancer.” Supportive Care in Cancer 24(11): 4533-4539.
Morel-Kopp, M. C., F. Mullier, V. Gkalea, T. Bakchoul, V. Minet, I. Elalamy, C. M. Ward and i. the subcommittee on platelet (2016). “Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH.” Journal of Thrombosis and Haemostasis 14(12): 2548-2552.
Morris, K. M., D. O’Meally, T. Zaw, X. Song, A. Gillett, M. P. Molloy, A. Polkinghorne and K. Belov (2016). “Characterisation of the immune compounds in koala milk using a combined transcriptomic and proteomic approach.” Scientific Reports 6.
Mulhall, B. P., S. T. Wright, N. De La Mata, D. Allen, K. Brown, B. Dickson, M. Grotowski, E. Jackson, K. Petoumenos, R. Foster, T. Read, D. Russell, D. J. Smith, D. J. Templeton, C. K. Fairley and M. G. Law (2016). “Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study.” HIV Medicine 17(8): 623-630.
Mulligan, S. P., C. M. Ward, D. Whalley and S. N. Hilmer (2016). “Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.” British Journal of Haematology 175(3): 359-364.
Muscat, D. M., S. Smith, H. M. Dhillon, S. Morony, E. L. Davis, K. Luxford, H. L. Shepherd, A. Hayen, J. Comings, D. Nutbeam and K. McCaffery (2016). “Incorporating health literacy in education for socially disadvantaged adults: An Australian feasibility study.” International Journal for Equity in Health 15(1).
Nadort, A., J. Zhao and E. M. Goldys (2016). “Lanthanide upconversion luminescence at the nanoscale: Fundamentals and optical properties.” Nanoscale 8(27): 13099-13130.
Naehrig, D. N., E. S. Koh, M. Vogiatzis, W. Yanagisawa, C. Kwong, H. L. Shepherd, C. Milross and H. M. Dhillon (2016). “Impact of cognitive function on communication in patients with primary or secondary brain tumours.” Journal of Neuro-Oncology 126(2): 299-307.
Nixon, I. J., L. Y. Wang, J. C. Migliacci, A. Eskander, M. J. Campbell, A. Aniss, L. Morris, F. Vaisman, R. Corbo, D. Momesso, M. Vaisman, A. Carvalho, D. Learoyd, W. D. Leslie, R. W. Nason, D. Kuk, V. Wreesmann, L. Morris, F. L. Palmer, I. Ganly, S. G. Patel, B. Singh, R. M. Tuttle, A. R. Shaha, M. Gönen, K. A. Pathak, W. T. Shen, M. Sywak, L. Kowalski, J. Freeman, N. Perrier and J. P. Shah (2016). “An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer.” Thyroid 26(3): 373-380.
Ochnik, A. M. and R. C. Baxter (2016). “Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.” Endocrine-Related Cancer 23(11): R527-R550.
Oh, B., T. Eade, A. Kneebone, N. Pavlakis, S. Clarke, G. Eslick, J. River and M. Back (2016). “Factors affecting whether or not cancer patients consider using acupuncture.” Acupuncture in Medicine.
Oh, B., G. Figtree, D. Costa, T. Eade, G. Hruby, S. Lim, A. Elfiky, N. Martine, D. Rosenthal, S. Clarke and M. Back (2016). “Oxidative stress in prostate cancer patients: A systematic review of case control studies.” Prostate International 4(3): 71-87.
Oh, D. D., K. Flitcroft, M. E. Brennan and A. J. Spillane (2016). “Patterns and outcomes of breast reconstruction in older women – A systematic review of the literature.” European Journal of Surgical Oncology 42(5): 604-615.
Oh, T. G., S. C. M. Wang, B. R. Acharya, J. M. Goode, J. D. Graham, C. L. Clarke, A. S. Yap and G. E. O. Muscat (2016). “The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.” EBioMedicine 6: 59-72.
Papaioannou, A., S. Kuyucak and Z. Kuncic (2016). “Elucidating the activation mechanism of the insulin-family proteins with molecular dynamics simulations.” PLoS ONE 11(8).
Papathomas, T. G., E. Pucci, T. J. Giordano, H. Lu, E. Duregon, M. Volante, M. Papotti, R. V. Lloyd, A. S. Tischler, F. H. Van Nederveen, V. Nose, L. Erickson, O. Mete, S. L. Asa, J. Turchini, A. J. Gill, X. Matias-Guiu, K. Skordilis, T. J. Stephenson, F. Tissier, R. A. Feelders, M. Smid, A. Nigg, E. Korpershoek, P. J. Van Der Spek, W. N. M. Dinjens, A. P. Stubbs and R. R. De Krijger (2016). “An international Ki67 reproducibility study in adrenal cortical Carcinoma.” American Journal of Surgical Pathology 40(4): 569-576.
Park, S. W., T. Eade, L. Pang, A. Wignall and D. Veivers (2016). “Role of neck dissection in metastatic squamous cell carcinoma to the parotid gland.” Journal of Laryngology and Otology 130(S4): S54-S59.
Parker, N. R., A. L. Hudson, P. Khong, J. F. Parkinson, T. Dwight, R. J. Ikin, Y. Zhu, Z. J. Cheng, F. Vafaee, J. Chen, H. R. Wheeler and V. M. Howell (2016). “Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.” Scientific Reports 6.
Patel, D., D. Chan, G. Cehic, N. Pavlakis and T. J. Price (2016). “Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors.” Expert Review of Endocrinology and Metabolism 11(4): 311-327.
Pavlakis, N., K. M. Sjoquist, A. J. Martin, E. Tsobanis, S. Yip, Y. K. Kang, Y. J. Bang, T. Alcindor, C. J. O’Callaghan, M. J. Burnell, N. C. Tebbutt, S. Y. Rha, J. Lee, J. Y. Cho, L. R. Lipton, M. Wong, A. Strickland, J. W. Kim, J. R. Zalcberg, J. Simes and D. Goldstein (2016). “Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial.” Journal of Clinical Oncology 34(23): 2728-2735.
Piccart-Gebhart, M., E. Holmes, J. Baselga, E. De Azambuja, A. C. Dueck, G. Viale, J. A. Zujewski, A. Goldhirsch, A. Armour, K. I. Pritchard, A. E. McCullough, S. Dolci, E. McFadden, A. P. Holmes, L. Tonghua, H. Eidtmann, P. Dinh, S. Di Cosimo, N. Harbeck, S. Tjulandin, Y. H. Im, C. S. Huang, V. Díeras, D. W. Hillman, A. C. Wolff, C. Jackisch, I. Lang, M. Untch, I. Smith, F. Boyle, B. Xu, H. Gomez, T. Suter, R. D. Gelber and E. A. Perez (2016). “Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial.” Journal of Clinical Oncology 34(10): 1034-1042.
Pollock, S., J. Kipritidis, D. Lee, K. Bernatowicz and P. Keall (2016). “The impact of breathing guidance and prospective gating during thoracic 4DCT imaging: An XCAT study utilizing lung cancer patient motion.” Physics in Medicine and Biology 61(17): 6485-6501.
Powell, K. L., V. Stevens, D. H. Upton, S. A. McCracken, A. M. Simpson, Y. Cheng, V. Tasevski, J. M. Morris and A. W. Ashton (2016). “Role for the thromboxane A 2 receptor β-isoform in the pathogenesis of intrauterine growth restriction.” Scientific Reports 6.
Pulvirenti, T., A. Hong, A. Clements, D. Forstner, A. Suchowersky, A. Guminski, C. McNeil, P. Hersey, G. Fogarty, R. Kefford, G. V. Long and W. Wang (2016). “Acute radiation skin toxicity associated with BRAF inhibitors.” Journal of Clinical Oncology 34(3): e17-e20.
Rainsford, S., R. D. Macleod, N. J. Glasgow, D. M. Wilson, C. B. Phillips and R. B. Wiles (2016). “Rural residents’ perspectives on the rural ‘good death’: A scoping review.” Health and Social Care in the Community.
Razali, W. A. W., V. K. A. Sreenivasan, C. Bradac, M. Connor, E. M. Goldys and A. V. Zvyagin (2016). “Front Cover: Wide-field time-gated photoluminescence microscopy for fast ultrahigh-sensitivity imaging of photoluminescent probes (J. Biophotonics 8/2016).” Journal of Biophotonics 9(8).
Razali, W. A. W., V. K. A. Sreenivasan, C. Bradac, M. Connor, E. M. Goldys and A. V. Zvyagin (2016). “Wide-field time-gated photoluminescence microscopy for fast ultrahigh-sensitivity imaging of photoluminescent probes.” Journal of Biophotonics 9(8): 848-858.
Reagh, J., M. Bullock, J. Andrici, J. Turchini, L. Sioson, A. Clarkson, N. Watson, A. Sheen, G. Lim, L. Delbridge, S. Sidhu, M. Sywak, A. Aniss, P. Shepherd, D. Ng, P. Oei, M. Field, D. Learoyd, B. G. Robinson, R. J. Clifton-Bligh and A. J. Gill (2016). “NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.” American Journal of Surgical Pathology.
Reagh, J. J. H., R. P. Eckstein, C. I. Selinger, J. Evans, S. A. O’Toole and A. J. Gill (2016). “Liposarcoma masquerading as an inflammatory pseudotumor: A case report.” Journal of Medical Case Reports 10(1).
Reid, G., S. C. Kao, N. Pavlakis, H. Brahmbhatt, J. MacDiarmid, S. Clarke, M. Boyer and N. Van Zandwijk (2016). “Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer.” Epigenomics 8(8): 1079-1085.
Reijneveld, J. C., M. J. B. Taphoorn, C. Coens, J. E. C. Bromberg, W. P. Mason, K. Hoang-Xuan, G. Ryan, M. B. Hassel, R. H. Enting, A. A. Brandes, A. Wick, O. Chinot, M. Reni, G. Kantor, B. Thiessen, M. Klein, E. Verger, C. Borchers, P. Hau, M. Back, A. Smits, V. Golfinopoulos, T. Gorlia, A. Bottomley, R. Stupp and B. G. Baumert (2016). “Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.” The Lancet Oncology 17(11): 1533-1542.
Ren, B., C. Tao, M. A. Swan, N. Joachim, R. Martiniello-Wilks, N. T. Nassif, B. A. O’Brien and A. M. Simpson (2016). “Pancreatic transdifferentiation and glucose-regulated production of human insulin in the H4IIE rat liver cell line.” International Journal of Molecular Sciences 17(4).
Rhee, Y. J., D. Houttekier, R. MacLeod, D. M. Wilson, M. Cardenas-Turanzas, M. Loucka, R. Aubry, J. Teno, S. Roh, M. A. Reinecke, L. Deliens and J. Cohen (2016). “International comparison of death place for suicide; a population-level eight country death certificate study.” Social Psychiatry and Psychiatric Epidemiology 51(1): 101-106.
Roberts, J. M., A. M. Cornall, D. Ekman, C. Law, I. M. Poynten, F. Jin, R. J. Hillman, D. J. Templeton, S. N. Tabrizi, S. M. Garland, J. K. Thurloe, A. E. Grulich and A. Farnsworth (2016). “Papillary immature metaplasia of the anal canal: A low-grade lesion that can mimic a high-grade lesion.” American Journal of Surgical Pathology 40(3): 348-353.
Roberts, J. M., F. Jin, J. K. Thurloe, D. Ekman, M. K. Adams, R. L. McDonald, C. Biro, I. M. Poynten, A. E. Grulich, A. Farnsworth, T. on behalf of The Study of the Prevention of Anal Cancer Study, B. Acraman, M. K. Adams, C. Biro, A. Carr, S. Carroll, D. Cooper, A. Cornall, L. Crampton, D. Ekman, C. Fairley, A. Farnsworth, L. Feeney, M. Garcia, S. Garland, R. Gluyas, A. E. Grulich, R. Hillman, K. Howard, F. Jin, C. Law, M. Law, D. Machalek, K. McCaffery, R. L. McDonald, P. McGrath, R. Mellor, S. Pendlebury, K. Petoumenos, P. Pezzopane, S. Phillips, I. Mary Poynten, G. Prestage, A. Richards, J. M. Roberts, D. Seeds, E. Segelov, S. Tabrizi, D. Templeton, J. K. Thurloe, W. Tong and R. Varma (2016). “The value of a transformation zone component in anal cytology to detect HSIL.” Cancer Cytopathology 124(8): 596-601.
Robinson, B., M. Schlumberger, L. J. Wirth, C. E. Dutcus, J. Song, M. H. Taylor, S. B. Kim, M. K. Krzyzanowska, J. Capdevila, S. I. Sherman and M. Tahara (2016). “Characterization of tumor size changes over time from the phase 3 study of lenvatinib in thyroid cancer.” Journal of Clinical Endocrinology and Metabolism 101(11): 4103-4109.
Russell, P. S., A. Mittal, L. Brown, C. McArthur, A. J. R. Phillips, M. Petrov and J. A. Windsor (2016). “Admission, management and outcomes of acute pancreatitis in intensive care.” ANZ Journal of Surgery.
Sanderson, C., S. J. Quinn, M. Agar, R. Chye, K. Clark, M. Doogue, B. Fazekas, J. Lee, M. R. Lovell, D. Rowett, O. Spruyt and D. C. Currow (2016). “Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain.” BMJ Supportive and Palliative Care 6(3): 323-330.
Schlichtemeier, S. M., T. C. Pang, N. E. Williams, A. J. Gill, R. C. Smith, J. S. Samra, V. W. T. Lam, M. Hollands, A. J. Richardson, H. C. Pleass, S. Nozawa, M. Albania and T. J. Hugh (2016). “A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.” European Journal of Surgical Oncology 42(10): 1576-1583.
Schnitzler, L., S. K. Smith, H. L. Shepherd, J. Shaw, S. Dong, D. M. Carpenter, F. Nguyen and H. M. Dhillon (2016). “Communication during radiation therapy education sessions: The role of medical jargon and emotional support in clarifying patient confusion.” Patient Education and Counseling.
Schofield, P. E., M. R. Stockler, D. Zannino, N. C. Tebbutt, T. J. Price, R. J. Simes, N. Wong, N. Pavlakis, D. Ransom, E. Moylan, C. Underhill, D. Wyld, I. Burns, R. Ward, N. Wilcken and M. Jefford (2016). “Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer.” Supportive Care in Cancer 24(1): 401-408.
Scully, T., S. M. Firth, C. D. Scott, H. C. de Silva, J. E. Pintar, T. Chan-Ling, S. M. Twigg and R. C. Baxter (2016). “Insulin-like growth factor binding protein-3 links obesity and breast cancer progression.” Oncotarget 7(34): 55491-55505.
Sedger, L. M., D. L. Tull, M. J. McConville, D. P. De Souza, T. W. T. Rupasinghe, S. J. Williams, S. Dayalan, D. Lanzer, H. Mackie, T. C. Lam and J. Boyages (2016). “Lipidomic profiling of adipose tissue reveals an inflammatory signature in cancer-related and primary Lymphedema.” PLoS ONE 11(5).
Segelov, E., S. Thavaneswaran, P. M. Waring, J. Desai, K. P. Robledo, V. J. Gebski, E. Elez, L. M. Nott, C. S. Karapetis, S. Lunke, L. A. Chantrill, N. Pavlakis, M. Khasraw, C. Underhill, F. Ciardiello, M. Jefford, H. Wasan, A. Haydon, T. J. Price, G. Van Hazel, K. Wilson, J. Simes and J. D. Shapiro (2016). “Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian gastro-intestinal trials group ICECREAM study.” Journal of Clinical Oncology 34(19): 2258-2264.
Segelov, E., P. Waring, J. Desai, K. Wilson, V. Gebski, S. Thavaneswaran, E. Elez, C. Underhill, N. Pavlakis, L. Chantrill, L. Nott, M. Jefford, M. Khasraw, F. Day, H. Wasan, F. Ciardiello, C. Karapetis, W. Joubert, G. Hazel, A. Haydon, T. Price, S. Tejpar, N. Tebbutt and J. Shapiro (2016). “ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.” BMC Cancer 16(1).
Seidler, Z. E., A. J. Dawes, S. M. Rice, J. L. Oliffe and H. M. Dhillon (2016). “The role of masculinity in men’s help-seeking for depression: A systematic review.” Clinical Psychology Review 49: 106-118.
Selinger, C. I., B. T. Li, N. Pavlakis, M. Links, A. J. Gill, A. Lee, S. Clarke, T. N. Tran, T. Lum, P. Y. Yip, L. Horvath, B. Yu, M. R. J. Kohonen-Corish, S. A. O’Toole and W. A. Cooper (2016). “Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.” Histopathology.
Shah, J. S., P. S. Soon and D. J. Marsh (2016). “Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs.” PLoS ONE 11(4).
Shaw, J., B. Baylock, A. O’Reilly, J. Winstanley, L. Pugliano, K. Andrews and F. Boyle (2016). “Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer.” Supportive Care in Cancer: 1-8.
Shaw, J. M., M. A. Price, J. M. Clayton, P. Grimison, T. Shaw, N. Rankin and P. N. Butow (2016). “Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process.” Supportive Care in Cancer 24(1): 33-41.
Sherman, K. A., L. K. E. Shaw, C. J. Winch, D. Harcourt, J. Boyages, L. D. Cameron, P. Brown, T. Lam, E. Elder, J. French and A. Spillane (2016). “Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled Trial.” Plastic and Reconstructive Surgery 138(4): 592e-602e.
Shi, X., R. Liu, F. Basolo, R. Giannini, X. Shen, D. Teng, H. Guan, Z. Shan, W. Teng, T. J. Musholt, K. Al-Kuraya, L. Fugazzola, C. Colombo, E. Kebebew, B. Jarzab, A. Czarniecka, B. Bendlova, V. Sykorova, M. Sobrinho-Simães, P. Soares, Y. K. Shong, T. Y. Kim, S. Cheng, S. L. Asa, D. Viola, R. Elisei, L. Yip, C. Mian, F. Vianello, Y. Wang, S. Zhao, G. Oler, J. M. Cerutti, E. Puxeddu, S. Qu, Q. Wei, H. Xu, C. J. O’Neill, M. S. Sywak, R. Clifton-Bligh, A. K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Yu, G. Tallini, E. H. Holt, V. Vasko and M. Xing (2016). “Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants.” Journal of Clinical Endocrinology and Metabolism 101(1): 264-274.
Simeoni, I., J. C. Stephens, F. Hu, S. V. V. Deevi, K. Megy, T. K. Bariana, C. Lentaigne, S. Schulman, S. Sivapalaratnam, M. J. A. Vries, S. K. Westbury, D. Greene, S. Papadia, M. C. Alessi, A. P. Attwood, M. Ballmaier, G. Baynam, E. Bermejo, M. Bertoli, P. F. Bray, L. Bury, M. Cattaneo, P. Collins, L. C. Daugherty, R. Favier, D. L. French, B. Furie, M. Gattens, M. Germeshausen, C. Ghevaert, A. C. Goodeve, J. A. Guerrero, D. J. Hampshire, D. P. Hart, J. W. M. Heemskerk, Y. M. C. Henskens, M. Hill, N. Hogg, J. D. Jolley, W. H. Kahr, A. M. Kelly, R. Kerr, M. Kostadima, S. Kunishima, M. P. Lambert, R. Liesner, J. A. López, R. P. Mapeta, M. Mathias, C. M. Millar, A. Nathwani, M. Neerman-Arbez, A. T. Nurden, P. Nurden, M. Othman, K. Peerlinck, D. J. Perry, P. Poudel, P. Reitsma, M. T. Rondina, P. A. Smethurst, W. Stevenson, A. Szkotak, S. Tuna, C. Van Geet, D. Whitehorn, D. A. Wilcox, B. Zhang, S. Revel-Vilk, P. Gresele, D. B. Bellissimo, C. J. Penkett, M. A. Laffan, A. D. Mumford, A. Rendon, K. Gomez, K. Freson, W. H. Ouwehand and E. Turro (2016). “A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.” Blood 127(23): 2791-2803.
Siva, S., T. Kron, M. Bressel, M. Haas, T. Mai, S. Vinod, G. Sasso, W. Wong, H. Le, T. Eade, N. Hardcastle, B. Chesson, D. Pham, M. Høyer, R. Montgomery and D. Ball (2016). “A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II).” BMC Cancer 16(1).
Smidt, K., L. Mackenzie, H. Dhillon, J. Vardy, J. Lewis and S. Y. Loh (2016). “The perceptions of Australian oncologists about cognitive changes in cancer survivors.” Supportive Care in Cancer: 1-9.
Smith, J., M. L. Read, J. Hoffman, R. Brown, B. Bradshaw, C. Campbell, T. Cole, J. D. Navas, F. Eatock, J. S. Gundara, E. Lian, D. McMullan, N. V. Morgan, L. Mulligan, P. J. Morrison, M. Robledo, M. A. Simpson, V. E. Smith, S. Stewart, R. C. Trembath, S. Sidhu, F. S. Togneri, N. C. Wake, Y. Wallis, J. C. Watkinson, E. R. Maher, C. J. McCabe and E. R. Woodward (2016). “Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.” Human Molecular Genetics 25(9): 1836-1845.
Smith, R. C., S. F. Smith, J. Wilson, C. Pearce, N. Wray, R. Vo, J. Chen, C. Y. Ooi, M. Oliver, T. Katz, R. Turner, M. Nikfarjam, C. Rayner, M. Horowitz, G. Holtmann, N. Talley, J. Windsor, R. Pirola and R. Neale (2016). “Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency.” Pancreatology 16(2): 164-180.
Smith, S. C., K. Trpkov, Y. B. Chen, R. Mehra, D. Sirohi, C. Ohe, A. K. Cani, D. H. Hovelson, K. Omata, J. B. McHugh, W. Jochum, M. Colecchia, M. Amin, M. K. Divatia, O. Hes, S. Menon, I. Werneck da Cunha, S. Tripodi, F. Brimo, A. J. Gill, A. O. Osunkoya, C. Magi-Galluzzi, M. Sibony, S. R. Williamson, G. Nesi, M. M. Picken, F. Maclean, A. Agaimy, L. Cheng, J. I. Epstein, V. E. Reuter, S. K. Tickoo, S. A. Tomlins and M. B. Amin (2016). “Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.” American Journal of Surgical Pathology.
Smith, S. K., B. Yan, C. Milross and H. M. Dhillon (2016). “Radiation therapy for people with cancer: what do written information materials tell them?” European Journal of Cancer Care 25(4): 675-685.
Soeberg, M. J., N. Creighton, D. C. Currow, J. M. Young and N. Van Zandwijk (2016). “Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.” Australian and New Zealand Journal of Public Health 40(3): 255-262.
Soeberg, M. J., J. Leigh, T. Driscoll, B. Armstrong, J. M. Young and N. Van Zandwijk (2016). “Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.” Occupational and Environmental Medicine 73(3): 187-194.
Soeberg, M. J., J. Leigh and N. van Zandwijk (2016). “Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends.” Journal of Toxicology and Environmental Health – Part B: Critical Reviews 19(5-6): 173-189.
Soeberg, M. J., M. A. Luong, T. Van Tran, A. T. Tran, T. T. H. Nguyen, D. Bui, T. H. N. Nguyen, K. Takahashi and N. Van Zandwijk (2016). “Estimating the incidence of malignant mesothelioma in Vietnam: A pilot descriptive cancer registration study.” International Journal of Occupational and Environmental Health 22(2): 167-172.
Song, X., A. Amirkhani, J. X. Wu, D. Pascovici, T. Zaw, D. Xavier, S. J. Clarke and M. P. Molloy (2016). “Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period.” Proteomics 16(15-16): 2118-2127.
Spillane, A. (2016). “Perceptions of increasing the complexity and commitment required for training breast surgeons.” ANZ Journal of Surgery 86(9): 633-634.
Spillane, A. J. (2016). “What is new in the surgical management and prevention of breast cancer?” Medical Journal of Australia 204(8): 311-314.e311.
Staerkle, R. F., R. J. E. Skipworth, S. Leibman and G. S. Smith (2016). “Emergency laparoscopic mesh repair of parahiatal hernia.” ANZ Journal of Surgery.
Stancliffe, R. J., M. Y. Wiese, S. Read, G. Jeltes and J. M. Clayton (2016). “Knowing, planning for and fearing death: Do adults with intellectual disability and disability staff differ?” Research in Developmental Disabilities 49-50: 47-59.
Startsev, M. A., M. Ostrowski, E. M. Goldys and D. W. Inglis (2016). “A mobility shift assay for DNA detection using nanochannel gradient electrophoresis.” Electrophoresis.
Steven, A., S. A. Fisher, B. W. Robinson, K. M. Fong and N. Van Zandwijk (2016). “Immunotherapy for lung cancer.” Respirology.
Stilgenbauer, S., B. Eichhorst, J. Schetelig, S. Coutre, J. F. Seymour, T. Munir, S. D. Puvvada, C. M. Wendtner, A. W. Roberts, W. Jurczak, S. P. Mulligan, S. Böttcher, M. Mobasher, M. Zhu, M. Desai, B. Chyla, M. Verdugo, S. H. Enschede, E. Cerri, R. Humerickhouse, G. Gordon, M. Hallek and W. G. Wierda (2016). “Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: A multicentre, open-label, phase 2 study.” The Lancet Oncology.
Strasser-Weippl, K., N. Horick, I. E. Smith, J. O’Shaughnessy, B. Ejlertsen, F. Boyle, A. U. Buzdar, P. Fumoleau, W. Gradishar, M. Martin, B. Moy, M. Piccart-Gebhart, K. I. Pritchard, D. Lindquist, E. Rappold, D. M. Finkelstein and P. E. Goss (2016). “Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.” European Journal of Cancer 56: 85-92.
Stuart, K. E. and J. Boyages (2016). “Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?-A commentary on the NSABP-B35 trial.” Translational Cancer Research 5: S113-S116.
Succar, P., M. Medynskyj, E. J. Breen, T. Batterham, M. P. Molloy and B. R. Herbert (2016). “Priming Adipose-Derived Mesenchymal Stem Cells with Hyaluronan Alters Growth Kinetics and Increases Attachment to Articular Cartilage.” Stem Cells International 2016.
Suo, H., C. Guo, J. Zheng, B. Zhou, C. Ma, X. Zhao, T. Li, P. Guo and E. M. Goldys (2016). “Sensitivity Modulation of Upconverting Thermometry through Engineering Phonon Energy of a Matrix.” ACS Applied Materials and Interfaces 8(44): 30312-30319.
Tebbutt, N. C., T. J. Price, D. A. Ferraro, N. Wong, A. S. Veillard, M. Hall, K. M. Sjoquist, N. Pavlakis, A. Strickland, S. C. Varma, P. Cooray, R. Young, C. Underhill, J. A. Shannon, V. Ganju and V. Gebski (2016). “Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.” British Journal of Cancer 114(5): 505-509.
The, N. G. S. i. P. S. G., R. A. Toledo, N. Burnichon, A. Cascon, D. E. Benn, J. P. Bayley, J. Welander, C. M. Tops, H. Firth, T. Dwight, T. Ercolino, M. Mannelli, G. Opocher, R. Clifton-Bligh, O. Gimm, E. R. Maher, M. Robledo, A. P. Gimenez-Roqueplo and P. L. M. Dahia (2016). “Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.” Nature Reviews Endocrinology.
Thevarajah, J. J., J. C. Bulanadi, M. Wagner, M. Gaborieau and P. Castignolles (2016). “Towards a less biased dissolution of chitosan.” Analytica Chimica Acta.
Tracy, I., W. Tapper, A. Parker, A. Gardiner, S. Sadullah, G. Pratt, A. Copplestone, D. Oscier and O. G. Best (2016). “Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.” British Journal of Haematology.
Trieu, P. D., W. Lee, K. Tapia and P. Brennan (2016). The effectiveness of the cranio-caudal mammogram projection among radiologists. Progress in Biomedical Optics and Imaging – Proceedings of SPIE.
Trpkov, K., O. Hes, A. Agaimy, M. Bonert, P. Martinek, C. Magi-Galluzzi, G. Kristiansen, C. Lüders, G. Nesi, E. Compérat, M. Sibony, D. M. Berney, R. Mehra, F. Brimo, A. Hartmann, A. Husain, N. Frizzell, K. Hills, F. Maclean, B. Srinivasan and A. J. Gill (2016). “Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.” American Journal of Surgical Pathology.
Trpkov, K., O. Hes, M. Bonert, J. I. Lopez, S. M. Bonsib, G. Nesi, E. Comperat, M. Sibony, D. M. Berney, P. Martinek, S. Bulimbasic, S. Suster, A. Sangoi, A. Yilmaz, J. P. Higgins, M. Zhou, A. J. Gill, C. G. Przybycin, C. Magi-Galluzzi and J. K. McKenney (2016). “Eosinophilic, solid, and cystic renal cell carcinoma.” American Journal of Surgical Pathology 40(1): 60-71.
Tsang, V. H. M., B. G. Robinson and D. L. Learoyd (2016). “The safety of vandetanib for the treatment of thyroid cancer.” Expert Opinion on Drug Safety 15(8): 1107-1113.
Turchini, J., J. Andrici, L. Sioson, A. Clarkson, N. Watson, C. W. Toon, P. Shepherd, D. Ng, A. Dixon-McIver, P. Oei and A. J. Gill (2016). “NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma.” Applied Immunohistochemistry and Molecular Morphology.
Udommethaporn, S., T. Tencomnao, E. M. McGowan and V. Boonyaratanakornkit (2016). “Assessment of anti-TNF-α activities in keratinocytes expressing inducible TNF- α: A novel tool for anti-TNF-α drug screening.” PLoS ONE 11(7).
Vafaee, F., J. R. Krycer, X. Ma, T. Burykin, D. E. James and Z. Kuncic (2016). “ORTI: An open-access Repository of transcriptional interactions for interrogating mammalian gene expression data.” PLoS ONE 11(10).
Van Dijk, A. H., P. R. De Reuver, T. N. Tasma, S. Van Dieren, T. J. Hugh and M. A. Boermeester (2016). “Systematic review of antibiotic treatment for acute calculous cholecystitis.” British Journal of Surgery 103(7): 797-811.
van Dooren, K., J. Dean, F. M. Boyle, M. Taylor-Gomez and N. G. Lennox (2016). “Consider the Support Worker in the Role of Health Assessments.” Journal of Applied Research in Intellectual Disabilities 29(6): 585-586.
van Grinsven, J., S. van Brunschot, O. J. Bakker, T. L. Bollen, M. A. Boermeester, M. J. Bruno, C. H. Dejong, M. G. Dijkgraaf, C. H. van Eijck, P. Fockens, H. van Goor, H. G. Gooszen, K. D. Horvath, K. P. van Lienden, H. C. van Santvoort and M. G. Besselink (2016). “Diagnostic strategy and timing of intervention in infected necrotizing pancreatitis: an international expert survey and case vignette study.” HPB 18(1): 49-56.
Van Zandwijk, N., M. Soeberg and G. Reid (2016). “Using a multidisciplinary approach to combat the burden of asbestos-related disease.” Medical Journal of Australia 204(2): 52-52.e51.
Vardy, J. L., H. M. Dhillon, G. R. Pond, C. Renton, A. Dodd, H. Zhang, S. J. Clarke and I. F. Tannock (2016). “Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: A longitudinal prospective study.” Annals of Oncology 27(9): 1761-1767.
Walczak, A., P. N. Butow, S. Bu and J. M. Clayton (2016). “A systematic review of evidence for end-of-life communication interventions: Who do they target, how are they structured and do they work?” Patient Education and Counseling 99(1): 3-16.
Wan Ismail, W. Z., E. M. Goldys and J. M. Dawes (2016). “Extended emission wavelength of random dye lasers by exploiting radiative and non-radiative energy transfer.” Applied Physics B: Lasers and Optics 122(2): 1-9.
Wang, J., J. Andrici, L. Sioson, A. Clarkson, A. Sheen, M. Farzin, C. W. Toon, J. Turchini and A. J. Gill (2016). “Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.” Human Pathology 55: 83-90.
Wann, A., D. Ashley and M. Khasraw (2016). “Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre.” Supportive Care in Cancer 24(7): 3023-3028.
Whalley, D., G. Hruby, F. Alfieri, A. Kneebone and T. Eade (2016). “SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity.” Clinical Oncology 28(10): e148-e154.
Wilson, D. M., N. Dhanji, R. Playfair, S. S. Nayak, G. L. Puplampu and R. Macleod (2016). “A scoping review of bereavement service outcomes.” Palliative and Supportive Care: 1-18.
Wilson, D. M., R. MacLeod and D. Houttekier (2016). “Examining Linkages between Bereavement Grief Intensity and Perceived Death Quality: Qualitative Findings.” Omega (United States) 74(2): 260-274.
Winch, C. J., K. A. Sherman, K. M. Smith, L. A. Koelmeyer, H. Mackie and J. Boyages (2016). ““You’re naked, you’re vulnerable”: Sexual well-being and body image of women with lower limb lymphedema.” Body Image 18: 123-134.
Wong, M. H., A. Xue, R. C. Baxter, N. Pavlakis and R. C. Smith (2016). “Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.” Neoplasia (United States).
Wong, S. F., L. Matheson, K. Morrissy, G. Pitson, D. M. Ashley, M. Khasraw, P. K. Lorgelly and M. J. Henry (2016). “Retrospective analysis of cancer survival across South-Western Victoria in Australia.” Australian Journal of Rural Health 24(2): 79-84.
Wong, S. F., R. Norman, T. L. Dunning, D. M. Ashley, M. Khasraw, T. M. Hayes, I. Collins and P. K. Lorgelly (2016). “A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointments.” JNCCN Journal of the National Comprehensive Cancer Network 14(3): 311-319.
Wong, Y. P., N. A. Sharifah, G. C. Tan, A. J. Gill and S. Z. Ali (2016). “Intrathyroidal oxyphilic parathyroid carcinoma: A potential diagnostic caveat in cytology?” Diagnostic Cytopathology.
Wrobel, E., I. Rothenberg, C. Krisp, F. Hundt, B. Fraenzel, K. Eckey, J. T. M. Linders, D. J. Gallacher, R. Towart, L. Pott, M. Pusch, T. Yang, D. M. Roden, H. T. Kurata, E. Schulze-Bahr, N. Strutz-Seebohm, D. Wolters and G. Seebohm (2016). “KCNE1 induces fenestration in the Kv7.1/KCNE1 channel complex that allows for highly specific pharmacological targeting.” Nature Communications 7.
Wu, J. X., X. Song, D. Pascovici, T. Zaw, N. Care, C. Krisp and M. P. Molloy (2016). “SWATH mass spectrometry performance using extended peptide MS/MS assay libraries.” Molecular and Cellular Proteomics 15(7): 2501-2514.
Zdenkowski, N., P. Butow, G. B. Mann, S. Fewster, C. Beckmore, R. Isaacs, C. Douglas and F. M. Boyle (2016). “A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.” Internal Medicine Journal 46(6): 677-683.
Zdenkowski, N., P. Butow, S. Tesson and F. Boyle (2016). “A systematic review of decision aids for patients making a decision about treatment for early breast cancer.” Breast 26: 31-45.
Zdenkowski, N., J. F. Forbes, F. M. Boyle, G. Kannourakis, P. G. Gill, E. Bayliss, C. Saunders, S. Della-Fiorentina, N. Kling, I. Campbell, G. B. Mann, A. S. Coates, V. Gebski, L. Davies, R. Thornton, L. Reaby, J. Cuzick and M. Green (2016). “Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial.” Annals of Oncology 27(5): 806-812.
Zdenkowski, N., S. Tesson, J. Lombard, M. Lovell, S. Hayes, P. A. Francis, H. M. Dhillon and F. M. Boyle (2016). “Supportive care of women with breast cancer: key concerns and practical solutions.” The Medical journal of Australia 205(10): 471-475.
Zeng, C., X. Guo, J. Long, K. B. Kuchenbaecker, A. Droit, K. Michailidou, M. Ghoussaini, S. Kar, A. Freeman, J. L. Hopper, R. L. Milne, M. K. Bolla, Q. Wang, J. Dennis, S. Agata, S. Ahmed, K. Aittomäki, I. L. Andrulis, H. Anton-Culver, N. N. Antonenkova, A. Arason, V. Arndt, B. K. Arun, B. Arver, F. Bacot, D. Barrowdale, C. Baynes, A. Beeghly-Fadiel, J. Benitez, M. Bermisheva, C. Blomqvist, W. J. Blot, N. V. Bogdanova, S. E. Bojesen, B. Bonanni, A. L. Borresen-Dale, J. S. Brand, H. Brauch, P. Brennan, H. Brenner, A. Broeks, T. Brüning, B. Burwinkel, S. S. Buys, Q. Cai, T. Caldes, I. Campbell, J. Carpenter, J. Chang-Claude, J. Y. Choi, K. B. M. Claes, C. Clarke, A. Cox, S. S. Cross, K. Czene, M. B. Daly, M. de la Hoya, K. De Leeneer, P. Devilee, O. Diez, S. M. Domchek, M. Doody, C. M. Dorfling, T. Dörk, I. dos-Santos-Silva, M. Dumont, M. Dwek, B. Dworniczak, K. Egan, U. Eilber, Z. Einbeigi, B. Ejlertsen, S. Ellis, D. Frost, F. Lalloo, P. A. Fasching, J. Figueroa, H. Flyger, M. Friedlander, E. Friedman, G. Gambino, Y. T. Gao, J. Garber, M. García-Closas, A. Gehrig, F. Damiola, F. Lesueur, S. Mazoyer, D. Stoppa-Lyonnet, G. G. Giles, A. K. Godwin, D. E. Goldgar, A. González-Neira, M. H. Greene, P. Guénel, L. Haeberle, C. A. Haiman, E. Hallberg, U. Hamann, T. V. O. Hansen, S. Hart, J. M. Hartikainen, M. Hartman, N. Hassan, S. Healey, F. B. L. Hogervorst, S. Verhoef, C. B. Hendricks, P. Hillemanns, A. Hollestelle, P. J. Hulick, D. J. Hunter, E. N. Imyanitov, C. Isaacs, H. Ito, A. Jakubowska, R. Janavicius, K. Jaworska-Bieniek, U. B. Jensen, E. M. John, C. Joly Beauparlant, M. Jones, M. Kabisch, D. Kang, B. Y. Karlan, S. Kauppila, M. J. Kerin, S. Khan, E. Khusnutdinova, J. A. Knight, I. Konstantopoulou, P. Kraft, A. Kwong, Y. Laitman, D. Lambrechts, C. Lazaro, L. Le Marchand, C. N. Lee, M. H. Lee, J. Lester, J. Li, A. Liljegren, A. Lindblom, A. Lophatananon, J. Lubinski, P. L. Mai, A. Mannermaa, S. Manoukian, S. Margolin, F. Marme, K. Matsuo, L. McGuffog, A. Meindl, F. Menegaux, M. Montagna, K. Muir, A. M. Mulligan, K. L. Nathanson, S. L. Neuhausen, H. Nevanlinna, P. A. Newcomb, S. Nord, R. L. Nussbaum, K. Offit, E. Olah, O. I. Olopade, C. Olswold, A. Osorio, L. Papi, T. W. Park-Simon, Y. Paulsson-Karlsson, S. Peeters, B. Peissel, P. Peterlongo, J. Peto, G. Pfeiler, C. M. Phelan, N. Presneau, P. Radice, N. Rahman, S. J. Ramus, M. U. Rashid, G. Rennert, K. Rhiem, A. Rudolph, R. Salani, S. Sangrajrang, E. J. Sawyer, M. K. Schmidt, R. K. Schmutzler, M. J. Schoemaker, P. Schürmann, C. Seynaeve, C. Y. Shen, M. J. Shrubsole, X. O. Shu, A. Sigurdson, C. F. Singer, S. Slager, P. Soucy, M. Southey, D. Steinemann, A. Swerdlow, C. I. Szabo, S. Tchatchou, M. R. Teixeira, S. H. Teo, M. B. Terry, D. C. Tessier, A. Teulé, M. Thomassen, L. Tihomirova, M. Tischkowitz, A. E. Toland, N. Tung, C. Turnbull, A. M. W. van den Ouweland, E. J. van Rensburg, D. ven den Berg, J. Vijai, S. Wang-Gohrke, J. N. Weitzel, A. S. Whittemore, R. Winqvist, T. Y. Wong, A. H. Wu, D. Yannoukakos, J. C. Yu, P. D. P. Pharoah, P. Hall, G. Chenevix-Trench, A. M. Dunning, J. Simard, F. J. Couch, A. C. Antoniou, D. F. Easton and W. Zheng (2016). “Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.” Breast Cancer Research 18(1).
Zheng, S., A. D. Cherniack, N. Dewal, R. A. Moffitt, L. Danilova, B. A. Murray, A. M. Lerario, T. Else, T. A. Knijnenburg, G. Ciriello, S. Kim, G. Assie, O. Morozova, R. Akbani, J. Shih, K. A. Hoadley, T. K. Choueiri, J. Waldmann, O. Mete, A. G. Robertson, H. T. Wu, B. J. Raphael, L. Shao, M. Meyerson, M. J. Demeure, F. Beuschlein, A. J. Gill, S. B. Sidhu, M. Q. Almeida, M. C. B. V. Fragoso, L. M. Cope, E. Kebebew, M. A. Habra, T. G. Whitsett, K. J. Bussey, W. E. Rainey, S. L. Asa, J. Bertherat, M. Fassnacht, D. A. Wheeler, G. D. Hammer, T. J. Giordano and R. G. W. Verhaak (2016). “Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.” Cancer Cell 29(5): 723-736.
Abbassi, R., T. G. Johns, M. Kassiou and L. Munoz (2015). “DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.” Pharmacology and Therapeutics 151: 87-98.
Akbani, R., K. C. Akdemir, B. A. Aksoy, M. Albert, A. Ally, S. B. Amin, H. Arachchi, A. Arora, J. T. Auman, B. Ayala, J. Baboud, M. Balasundaram, S. Balu, N. Barnabas, J. Bartlett, P. Bartlett, B. C. Bastian, S. B. Baylin, M. Behera, D. Belyaev, C. Benz, B. Bernard, R. Beroukhim, N. Bir, A. D. Black, T. Bodenheimer, L. Boice, G. M. Boland, R. Bono, M. S. Bootwalla, M. Bosenberg, J. Bowen, R. Bowlby, C. A. Bristow, L. Brockway-Lunardi, D. Brooks, J. Brzezinski, W. Bshara, E. Buda, W. R. Burns, Y. S. N. Butterfield, M. Button, T. Calderone, G. A. Cappellini, C. Carter, S. L. Carter, L. Cherney, A. D. Cherniack, A. Chevalier, L. Chin, J. Cho, R. J. Cho, Y. L. Choi, A. Chu, S. Chudamani, K. Cibulskis, G. Ciriello, A. Clarke, S. Coons, L. Cope, D. Crain, E. Curley, L. Danilova, S. D’Atri, T. Davidsen, M. A. Davies, K. A. Delman, J. A. Demchok, Q. A. Deng, Y. L. Deribe, N. Dhalla, R. Dhir, D. Dicara, M. Dinikin, M. Dubina, J. S. Ebrom, S. Egea, G. Eley, J. Engel, J. M. Eschbacher, K. V. Fedosenko, I. Felau, T. Fennell, M. L. Ferguson, S. Fisher, K. T. Flaherty, S. Frazer, J. Frick, V. Fulidou, S. B. Gabriel, J. Gao, J. Gardner, L. A. Garraway, J. M. Gastier-Foster, C. Gaudioso, N. Gehlenborg, G. Genovese, M. Gerken, J. E. Gershenwald, G. Getz, C. Gomez-Fernandez, T. Gribbin, J. Grimsby, B. Gross, R. Guin, T. Gutschner, A. Hadjipanayis, R. Halaban, B. Hanf, D. Haussler, L. E. Haydu, D. N. Hayes, N. K. Hayward, D. I. Heiman, L. Herbert, J. G. Herman, P. Hersey, K. A. Hoadley, E. Hodis, R. A. Holt, D. S. Hoon, S. Hoppough, A. P. Hoyle, F. W. Huang, M. Huang, S. Huang, C. M. Hutter, M. Ibbs, L. Iype, A. Jacobsen, V. Jakrot, A. Janning, W. R. Jeck, S. R. Jefferys, M. A. Jensen, C. D. Jones, S. J. M. Jones, Z. Ju, H. Kakavand, H. Kang, R. F. Kefford, F. R. Khuri, J. Kim, J. M. Kirkwood, J. Klode, A. Korkut, K. Korski, M. Krauthammer, R. Kucherlapati, L. N. Kwong, W. Kycler, M. Ladanyi, P. H. Lai, P. W. Laird, E. Lander, M. S. Lawrence, A. J. Lazar, R. Łaźniak, D. Lee, J. E. Lee, J. Lee, K. Lee, S. Lee, W. Lee, E. Leporowska, K. M. Leraas, H. I. Li, T. M. Lichtenberg, L. Lichtenstein, P. Lin, S. Ling, J. Liu, O. Liu, W. Liu, G. V. Long, Y. Lu, S. Ma, Y. Ma, A. Mackiewicz, H. S. Mahadeshwar, J. Malke, D. Mallery, G. M. Manikhas, G. J. Mann, M. A. Marra, B. Matejka, M. Mayo, S. Mehrabi, S. Meng, M. Meyerson, P. A. Mieczkowski, J. P. Miller, M. L. Miller, G. B. Mills, F. Moiseenko, R. A. Moore, S. Morris, C. Morrison, D. Morton, S. Moschos, L. E. Mose, F. L. Muller, A. J. Mungall, D. Murawa, P. Murawa, B. A. Murray, L. Nezi, S. Ng, D. Nicholson, M. S. Noble, A. Osunkoya, T. K. Owonikoko, B. A. Ozenberger, E. Pagani, O. V. Paklina, A. Pantazi, M. Parfenov, J. Parfitt, P. J. Park, W. Y. Park, J. S. Parker, F. Passarelli, R. Penny, C. M. Perou, T. D. Pihl, O. Potapova, V. G. Prieto, A. Protopopov, M. J. Quinn, A. Radenbaugh, K. Rai, S. S. Ramalingam, A. T. Raman, N. C. Ramirez, R. Ramirez, U. Rao, W. K. Rathmell, X. Ren, S. M. Reynolds, J. Roach, A. G. Robertson, M. I. Ross, J. Roszik, G. Russo, G. Saksena, C. Saller, Y. Samuels, C. Sander, C. Sander, G. Sandusky, N. Santoso, M. Saul, R. P. Saw, D. Schadendorf, J. E. Schein, N. Schultz, S. E. Schumacher, C. Schwallier, R. A. Scolyer, J. Seidman, P. C. Sekhar, H. S. Sekhon, Y. Senbabaoglu, S. Seth, K. F. Shannon, S. Sharpe, N. E. Sharpless, K. R. M. Shaw, C. Shelton, T. Shelton, R. Shen, M. Sheth, Y. Shi, C. J. Shiau, I. Shmulevich, G. L. Sica, J. V. Simons, R. Sinha, P. Sipahimalani, H. J. Sofia, M. G. Soloway, X. Song, C. Sougnez, A. J. Spillane, A. Spychała, J. R. Stretch, J. Stuart, W. M. Suchorska, A. Sucker, S. O. Sumer, Y. Sun, M. Synott, B. Tabak, T. R. Tabler, A. Tam, D. Tan, J. Tang, R. Tarnuzzer, K. Tarvin, H. Tatka, B. S. Taylor, M. Teresiak, N. Thiessen, J. F. Thompson, L. Thorne, V. Thorsson, J. M. Trent, T. J. Triche, K. Y. Tsai, P. Tsou, D. J. Van Den Berg, E. M. Van Allen, U. Veluvolu, R. G. Verhaak, D. Voet, O. Voronina, V. Walter, J. S. Walton, Y. Wan, Y. Wang, Z. Wang, S. Waring, I. R. Watson, N. Weinhold, J. N. Weinstein, D. J. Weisenberger, P. White, M. D. Wilkerson, J. S. Wilmott, L. Wise, M. Wiznerowicz, S. E. Woodman, C. J. Wu, C. C. Wu, J. Wu, Y. Wu, R. Xi, A. W. Xu, D. Yang, L. Yang, L. Yang, T. I. Zack, J. C. Zenklusen, H. Zhang, J. Zhang, W. Zhang, X. Zhao, J. Zhu, K. Zhu, L. Zimmer, E. Zmuda and L. Zou (2015). “Genomic Classification of Cutaneous Melanoma.” Cell 161(7): 1681-1696.
Al Khamici, H., L. J. Brown, K. R. Hossain, A. L. Hudson, A. A. Sinclair-Burton, J. P. Ng, E. L. Daniel, J. E. Hare, B. A. Cornell, P. M. Curmi, M. W. Davey and S. M. Valenzuela (2015). “Members of the chloride intracellular ion channel protein family demonstrate glutaredoxin-like enzymatic activity.” PloS one 10(1): e115699.
Albrecht, M. A., C. Szoeke, P. Maruff, G. Savage, N. T. Lautenschlager, K. A. Ellis, K. Taddei, R. Martins, C. L. Masters, D. Ames and J. K. Foster (2015). “Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status.” Neuropsychologia 75: 411-419.
Ampt, A. J., C. L. Roberts, J. M. Morris and J. B. Ford (2015). “The impact of first birth obstetric anal sphincter injury on the subsequent birth: A population-based linkage study.” BMC Pregnancy and Childbirth 15(1).
Anforth, R., G. Carlos, A. Clements, R. Kefford and P. Fernandez-Peñas (2015). “Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks.” British Journal of Dermatology 172(1): 239-243.
Anforth, R., A. Menzies, K. Byth, G. Carlos, S. Chou, R. Sharma, R. A. Scolyer, R. Kefford, G. V. Long and P. Fernandez-Peñas (2015). “Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy.” Journal of the American Academy of Dermatology 72(5): 809-815.
Archer, N. S., N. T. Nassif and B. A. O’Brien (2015). “Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: Systematic review and meta-analysis.” Genes and Immunity 16(4): 275-283.
Ardi Handojoseno, A. M., J. M. Shine, T. N. Nguyen, Y. Tran, S. J. G. Lewis and H. T. Nguyen (2015). “Analysis and prediction of the freezing of gait using EEG brain dynamics.” IEEE Transactions on Neural Systems and Rehabilitation Engineering 23(5): 887-896.
Austin, C. J. D., M. Moir, J. Kahlert, J. R. Smith, J. F. Jamie, M. Kassiou and L. M. Rendina (2015). “Carborane-Containing Hydroxyamidine Scaffolds as Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 (IDO1).” Australian Journal of Chemistry 68(12): 1866-1870.
Bailey, D. L., T. M. Hennessy, K. P. Willowson, E. C. Henry, D. L. H. Chan, A. Aslani and P. J. Roach (2015). “In vivo quantification of 177Lu with planar whole-body and SPECT/CT gamma camera imaging.” EJNMMI Physics 2(1): 1-17.
Bakmiwewa, S. M., B. Heng, G. J. Guillemin, H. J. Ball and N. H. Hunt (2015). “An effective, low-cost method for achieving and maintaining hypoxia during cell culture studies.” BioTechniques 59(4): 223-229.
Banister, S. D., C. Beinat, S. M. Wilkinson, B. Shen, C. Bartoli, S. Selleri, E. Da Pozzo, C. Martini, F. T. Chin and M. Kassiou (2015). “Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO).” European Journal of Medicinal Chemistry 93: 392-400.
Banister, S. D., M. Moir, J. Stuart, R. C. Kevin, K. E. Wood, M. Longworth, S. M. Wilkinson, C. Beinat, A. S. Buchanan, M. Glass, M. Connor, I. S. McGregor and M. Kassiou (2015). “Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.” ACS Chemical Neuroscience 6(9): 1546-1559.
Banister, S. D., J. Stuart, T. Conroy, M. Longworth, M. Manohar, C. Beinat, S. M. Wilkinson, R. C. Kevin, D. E. Hibbs, M. Glass, M. Connor, I. S. McGregor and M. Kassiou (2015). “Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues.” Forensic Toxicology 33(2): 355-366.
Bannister-Tyrrell, M., J. A. Patterson, J. B. Ford, J. M. Morris, M. C. Nicholl and C. L. Roberts (2015). “Variation in hospital caesarean section rates for preterm births.” Australian and New Zealand Journal of Obstetrics and Gynaecology 55(4): 350-356.
Beinat, C., S. D. Banister, M. Herrera, V. Law and M. Kassiou (2015). “The Therapeutic Potential of α<inf>7</inf> Nicotinic Acetylcholine Receptor (α<inf>7</inf> nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia.” CNS Drugs 29(7): 529-542.
Beinat, C., T. Reekie, S. D. Banister, J. O’Brien-Brown, T. Xie, T. T. Olson, Y. Xiao, A. Harvey, S. O’Connor, C. Coles, A. Grishin, P. Kolesik, J. Tsanaktsidis and M. Kassiou (2015). “Structure-activity relationship studies of SEN12333 analogues: Determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs.” European Journal of Medicinal Chemistry 95: 277-301.
Benn, D. E., B. G. Robinson and R. J. Clifton-Bligh (2015). “Clinical manifestations of paraganglioma syndromes types 1-5.” Endocrine-Related Cancer 22(4): T91-T103.
Bill, R., E. Fagiani, A. Zumsteg, H. Antoniadis, D. Johansson, S. Haefliger, I. Albrecht, F. Hilberg and G. Christofori (2015). “Nintedanib is a highly effective therapeutic for neuroendocrine carcinoma of the pancreas (PNET) in the Rip1Tag2 transgenic mouse model.” Clinical Cancer Research 21(21): 4856-4867.
Birnie, K. A., Y. Y. Yip, D. C. H. Ng, M. B. Kirschner, G. Reid, C. M. Prêle, A. W. Musk, Y. C. G. Lee, P. J. Thompson, S. E. Mutsaers and B. Badrian (2015). “Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma.” Molecular Cancer Research 13(7): 1106-1118.
Bogaardt, H., L. Veerbeek, K. Kelly, A. van der Heide, L. van Zuylen and R. Speyer (2015). “Swallowing Problems at the End of the Palliative Phase: Incidence and Severity in 164 Unsedated Patients.” Dysphagia 30(2): 145-151.
Buckley, R., M. Saling, K. Ellis, C. Rowe, P. Maruff, L. S. Macaulay, R. Martins, C. Masters, G. Savage, S. Rainey-Smith, A. Rembach and D. Ames (2015). “Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment.” Age and Ageing 44(6): 1012-1019.
Buckley, R. F., K. A. Ellis, D. Ames, C. C. Rowe, N. T. Lautenschlager, P. Maruff, V. L. Villemagne, S. Lance Macaulay, C. Szoeke, R. N. Martins, C. L. Masters, G. Savage, S. R. Rainey-Smith, A. Rembach and M. M. Saling (2015). “Phenomenological characterization of memory complaints in preclinical and prodromal alzheimer’s disease.” Neuropsychology 29(4): 571-581.
Burianová, H., A. N. Rich, M. Williams, M. Morgan, L. Marstaller, P. Maruff, C. I. Baker and G. Savage (2015). “Long-term plasticity in adult somatosensory cortex: functional reorganization after surgical removal of an arteriovenous malformation.” Neurocase 21(5): 618-627.
Burnham, S. C., N. Raghavan, W. Wilson, D. Baker, M. T. Ropacki, G. Novak, D. Ames, K. Ellis, R. N. Martins, P. Maruff, C. L. Masters, G. Romano, C. C. Rowe, G. Savage, S. L. Macaulay and V. A. Narayan (2015). “Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer’s Disease Trials: An AIBL Study.” Journal of Alzheimer’s Disease 46(4): 1079-1089.
Carlino, M. S., C. Fung, H. Shahheydari, J. R. Todd, S. C. Boyd, M. Irvine, A. M. Nagrial, R. A. Scolyer, R. F. Kefford, G. V. Long and H. Rizos (2015). “Preexisting MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients.” Clinical Cancer Research 21(1): 98-105.
Carlino, M. S., V. Kwan, D. K. Miller, C. A. B. Saunders, D. Yip, A. M. Nagrial, J. Tomlinson, S. M. Grimmond, R. A. Scolyer, R. F. Kefford, A. V. Biankin and G. V. Long (2015). “New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.” Journal of Clinical Oncology 33(11): e52-e56.
Chakiath, R. J., P. J. Siddall, J. E. Kellow, J. M. Hush, M. P. Jones, A. Marcuzzi and P. J. Wrigley (2015). “Descending pain modulation in irritable bowel syndrome (IBS): A systematic review and meta-analysis.” Systematic Reviews 4(1).
Chan, M. M. K., R. F. Kefford, M. Carlino, A. Clements and N. Manolios (2015). “Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.” Journal of Immunotherapy 38(1): 37-39.
Chin, V. T., A. M. Nagrial, A. Chou, A. V. Biankin, A. J. Gill, P. Timpson and M. Pajic (2015). “Rho-associated kinase signalling and the cancer microenvironment: Novel biological implications and therapeutic opportunities.” Expert Reviews in Molecular Medicine 17.
Chou, A., S. Fraser, C. W. Toon, A. Clarkson, L. Sioson, M. Farzin, C. Cussigh, A. Aniss, C. O’Neill, N. Watson, R. J. Clifton-Bligh, D. L. Learoyd, B. G. Robinson, C. I. Selinger, L. W. Delbridge, S. B. Sidhu, S. A. O’Toole, M. Sywak and A. J. Gill (2015). “A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.” American Journal of Surgical Pathology 39(5): 652-659.
Chung, L., L. Phillips, M. Z. Lin, K. Moore, D. J. Marsh, F. M. Boyle and R. C. Baxter (2015). “A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer.” Cancer Letters 368(1): 64-70.
Clifton-Bligh, P. B., M. L. Nery, R. Supramaniam, T. S. Reeve, L. Delbridge, J. N. Stiel, A. McElduff, E. G. Wilmshurst, B. G. Robinson, G. R. Fulcher, D. Learoyd and S. Posen (2015). “Mortality associated with primary hyperparathyroidism.” Bone 74: 121-124.
Collins, A. M., C. S. Quinlan, R. T. Dolan, S. P. O’Neill, P. Tierney, K. J. Cronin and P. F. Ridgway (2015). “Audiovisual preconditioning enhances the efficacy of an anatomical dissection course: A randomised study.” Journal of Plastic, Reconstructive and Aesthetic Surgery 68(7): 1010-1015.
Coughlin, J. M., Y. Wang, C. A. Munro, S. Ma, C. Yue, S. Chen, R. Airan, P. K. Kim, A. V. Adams, C. Garcia, C. Higgs, H. I. Sair, A. Sawa, G. Smith, C. G. Lyketsos, B. Caffo, M. Kassiou, T. R. Guilarte and M. G. Pomper (2015). “Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study.” Neurobiology of Disease 74: 58-65.
Cust, A. E., K. M. Pickles, C. Goumas, T. Vu, H. Schmid, E. Nagore, J. Kelly, J. F. Aitken, G. G. Giles, J. L. Hopper, M. A. Jenkins and G. J. Mann (2015). “Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian Adults.” Cancer Epidemiology Biomarkers and Prevention 24(4): 736-743.
Davis, I. D., A. Long, S. Yip, D. Espinoza, J. F. Thompson, G. Kichenadasse, M. Harrison, R. M. Lowenthal, N. Pavlakis, A. Azad, G. Kannourakis, C. Steer, D. Goldstein, J. Shapiro, R. Harvie, L. Jovanovic, A. L. Hudson, C. C. Nelson, M. R. Stockler and A. Martin (2015). “EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.” Annals of Oncology 26(6): 1118-1123.
Ding, L. E., L. Burnett and D. Chesher (2015). “The impact of reporting incidental findings from exome and whole-genome sequencing: Predicted frequencies based on modeling.” Genetics in Medicine 17(3): 197-204.
Duggleby, W., S. Kuchera, R. MacLeod, P. Holyoke, T. Scott, L. Holtslander, A. Letendre, T. Moeke-Maxwell, L. Burhansstipanov and T. Chambers (2015). “Indigenous people’s experiences at the end of life.” Palliative & supportive care 13(6): 1721-1733.
Eslick, E. M. and P. J. Keall (2015). “The Nano-X Linear Accelerator: A Compact and Economical Cancer Radiotherapy System Incorporating Patient Rotation.” Technology in cancer research & treatment 14(5): 565-572.
Espinosa, E., J. J. Grob, R. Dummer, P. Rutkowski, C. Robert, H. Gogas, R. Kefford, A. M. M. Eggermont, S. Martin Algarra, A. Hauschild and D. Schadendorf (2015). “Treatment algorithms in stage IV melanoma.” American Journal of Therapeutics 22(1): 61-67.
Farber, A., T. W. Tan, B. Hu, L. M. Dember, G. J. Beck, B. S. Dixon, J. W. Kusek, H. I. Feldman, L. Dember, J. Kaufman, M. Hawley, A. Lauer, P. Lesage, R. Nathan, E. Holmberg, G. Braden, M. Ryan, A. Berkowitz, A. Rahman, B. Lucas, R. Santos, B. Reyes, A. Greenberg, M. Berkoben, E. Kovalik, J. Lawson, J. Middleton, S. Schwab, D. Schumm, S. Adams, K. Gitter, T. Cantaffa, A. Quarles, J. Work, S. Rhodes, J. Himmelfarb, J. Whiting, J. Kane, S. Freedman, R. Violette, H. Cyr-Alves, K. Garrison, K. Martin, P. Schmitz, V. Jenkins, J. Cotton, E. Husband, M. Allon, M. Robbin, M. Lockhart, B. Casey, J. Newsome, B. Dixon, B. Franzwa, L. Hunsicker, J. Hoballah, D. Katz, W. Sharp, T. Kresowik, Y. Wu, S. Rayhill, T. Pflederer, K. Dupage, K. Welch, F. Darras, A. Banqero, B. Ketel, A. Wounded Arrow, M. Vazquez, I. Davidson, R. Toto, L. Littmon, C. Ying, T. Lightfoot, H. Quinones, R. Saxena, P. Clagett, J. Valentine, B. Dolmatch, J. Thompson, A. Fenves, G. Pearl, A. Ikizler, P. Egbert, J. McNeil, D. Holmes, W. Freiberger, J. Delmez, D. Windus, D. Coyne, M. Rothstein, S. Shenoy, R. Creaghan, B. Lluka, J. Kusek, C. Meyers, H. Feldman, G. Beck, J. Gassman, T. Greene, B. Hu, S. Bi, A. Liu, M. Radeva, L. Tuason, B. Weiss, N. Levin, A. Besarab, G. Chertow, M. Diener-West, T. Louis, W. McClellan and C. Stehman-Breen (2015). “The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts Presented at the 2013 Vascular Annual Meeting for the Society of Vascular Surgery, San Francisco, Calif, May 30-June 1, 2013.” Journal of Vascular Surgery 62(5): 1258-1265.
Farzin, M., C. W. Toon, A. Clarkson, L. Sioson, N. Watson, J. Andrici and A. J. Gill (2015). “Loss of expression of BAP1 predicts longer survival in mesothelioma.” Pathology 47(4): 302-307.
Feletto, E., A. Bang, D. Cole-Clark, V. Chalasani, K. Rasiah and D. P. Smith (2015). “An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?” World Journal of Urology 33(11): 1677-1687.
Finnerup, N. B., N. Attal, S. Haroutounian, E. McNicol, R. Baron, R. H. Dworkin, I. Gilron, M. Haanpää, P. Hansson, T. S. Jensen, P. R. Kamerman, K. Lund, A. Moore, S. N. Raja, A. S. C. Rice, M. Rowbotham, E. Sena, P. Siddall, B. H. Smith and M. Wallace (2015). “Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis.” The Lancet Neurology 14(2): 162-173.
Flynn, A., D. Benn, R. Clifton-Bligh, B. Robinson, A. H. Trainer, P. James, A. Hogg, K. Waldeck, J. George, J. Li, S. B. Fox, A. J. Gill, G. McArthur, R. J. Hicks and R. W. Tothill (2015). “The genomic landscape of phaeochromocytoma.” Journal of Pathology 236(1): 78-89.
Fogarty, G. B., A. Hong, K. Dolven-Jacobsen, C. H. Reisse, B. Burmeister, L. H. Haydu, H. Dhillon, V. Steel, B. Shivalingam, K. Drummond, J. Vardy, A. Nowak, G. Hruby, R. A. Scolyer, C. Mandel and J. F. Thompson (2015). “First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality.” BMC Research Notes 8(1).
Fogarty, G. B., A. Hong and J. F. Thompson (2015). “Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy?” The Lancet Oncology 16(5): e195-e196.
Gholami, Y., X. Zhu, R. Fulton, S. Meikle, G. El-Fakhri and Z. Kuncic (2015). “Stochastic simulation of radium-223 dichloride therapy at the sub-cellular level.” Physics in Medicine and Biology 60(15): 6087-6096.
Gifford, G., K. Wong, I. Kerridge, W. Stevenson, C. Arthur, K. Fay and M. Greenwood (2015). “Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies.” American Journal of Hematology 90(5): E97-E100.
Glover, A. R., J. T. Zhao, A. J. Gill, J. Weiss, N. Mugridge, E. Kim, A. L. Feeney, J. C. Ip, G. Reid, S. Clarke, P. S. Soon, B. G. Robinson, H. Brahmbhatt, J. A. MacDiarmid and S. B. Sidhu (2015). “microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.” Oncotarget 6(34): 36675-36688.
Goh, A., K. Browning Carmo, J. Morris, A. Berry, M. Wall and M. Abdel-Latif (2015). “Outcomes of high-risk obstetric transfers in New South Wales and the Australian Capital Territory: The High-Risk Obstetric Transfer Study.” Australian and New Zealand Journal of Obstetrics and Gynaecology 55(5): 434-439.
Gowrishankar, K., D. Gunatilake, S. J. Gallagher, J. Tiffen, H. Rizos and P. Hersey (2015). “Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.” PLoS ONE 10(4).
Gray, E. S., H. Rizos, A. L. Reid, S. C. Boyd, M. R. Pereira, J. Lo, V. Tembe, J. Freeman, J. H. J. Lee, R. A. Scolyer, K. Siew, C. Lomma, A. Cooper, M. A. Khattak, T. M. Meniawy, G. V. Long, M. S. Carlino, M. Millward and M. Ziman (2015). “Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.” Oncotarget 6(39): 42008-42018.
Guest, J., G. J. Guillemin, B. Heng and R. Grant (2015). “Lycopene pretreatment ameliorates acute ethanol induced NAD<sup>+</sup> depletion in human astroglial cells.” Oxidative Medicine and Cellular Longevity 2015.
Gurgis, F. M. S., Y. T. Yeung, M. X. M. Tang, B. Heng, M. Buckland, A. J. Ammit, J. Haapasalo, H. Haapasalo, G. J. Guillemin, T. Grewal and L. Munoz (2015). “The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.” Oncogene 34(22): 2934-2942.
Haass, N. K., N. Nassif and E. M. McGowan (2015). “Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.” BioMed Research International 2015.
Hall, J. M., M. Gilat, S. J. G. Lewis and J. M. Shine (2015). “Does dominant pedunculopontine nucleus exist? Probably not.” Brain 138(5): e346.
Hall, J. M., J. M. Shine, C. O’Callaghan, C. C. Walton, M. Gilat, S. L. Naismith and S. J. G. Lewis (2015). “Freezing of gait and its associations in the early and advanced clinical Motor Stages of Parkinson’s Disease: A cross-sectional study.” Journal of Parkinson’s Disease 5(4): 881-891.
Handojoseno, A. M. A., M. Gilat, Q. T. Ly, H. Chamtie, J. M. Shine, T. N. Nguyen, Y. Tran, S. J. G. Lewis and H. T. Nguyen (2015). An EEG study of turning freeze in Parkinson’s disease patients: The alteration of brain dynamic on the motor and visual cortex. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.
Hayne, D., M. Stockler, S. P. McCombie, V. Chalasani, A. Long, A. Martin, S. Sengupta and I. D. Davis (2015). “BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301).” BMC Cancer 15(1).
Heinemann, A., C. Cullinane, R. De Paoli-Iseppi, J. S. Wilmott, D. Gunatilake, J. Madore, D. Strbenac, J. Y. Yang, K. Gowrishankar, J. C. Tiffen, R. K. Prinjha, N. Smithers, G. A. McArthur, P. Hersey and S. J. Gallagher (2015). “Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling.” Oncotarget 6(25): 21507-21521.
Heng, B., C. K. Lim, D. B. Lovejoy, A. Bessede, L. Gluch and G. J. Guillemin (2015). “Understanding the role of the kynurenine pathway in human breast cancer immunobiology.” Oncotarget 7(6): 6506-6520.
Hersey, P. and K. Gowrishankar (2015). “Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma.” Future Oncology 11(1): 133-140.
Horwitz, S., B. Coiffier, F. Foss, H. M. Prince, L. Sokol, M. Greenwood, D. Caballero, F. Morschhauser, L. Pinter-Brown, S. P. Iyer, A. Shustov, J. Nichols, J. Balser, B. Balser and B. Pro (2015). “Utility of <sup>18</sup>fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.” Annals of Oncology 26(4): 774-779.
Hosie, A., E. Lobb, M. Agar, P. M. Davidson, R. Chye and J. Phillips (2015). “Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: A focus group study.” Journal of Clinical Nursing 24(21-22): 3276-3285.
Huang, C. Y., J. N. Tehrani, J. A. Ng, J. Booth and P. Keall (2015). “Six degrees-of-freedom prostate and lung tumor motion measurements using kilovoltage intrafraction monitoring.” International Journal of Radiation Oncology Biology Physics 91(2): 368-375.
Jankova, L., O. F. Dent, M. P. Molloy, C. Chan, P. H. Chapuis, V. M. Howell and S. J. Clarke (2015). “Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.” Proteomics – Clinical Applications 9(11-12): 1078-1086.
Jayawardana, K., S. J. Schramm, L. Haydu, J. F. Thompson, R. A. Scolyer, G. J. Mann, S. Müller and J. Y. H. Yang (2015). “Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.” International Journal of Cancer 136(4): 863-874.
Jenkins, M. G., J. B. Ford, A. L. Todd, R. Forsyth, J. M. Morris and C. L. Roberts (2015). “Women’s views about maternity care: How do women conceptualise the process of continuity?” Midwifery 31(1): 25-30.
Johnson, D. B., A. M. Menzies, L. Zimmer, Z. Eroglu, F. Ye, S. Zhao, H. Rizos, A. Sucker, R. A. Scolyer, R. Gutzmer, H. Gogas, R. F. Kefford, J. F. Thompson, J. C. Becker, C. Berking, F. Egberts, C. Loquai, S. M. Goldinger, G. M. Pupo, W. Hugo, X. Kong, L. A. Garraway, J. A. Sosman, A. Ribas, R. S. Lo, G. V. Long and D. Schadendorf (2015). “Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.” European Journal of Cancer 51(18): 2792-2799.
Juneja, P., H. Caine, P. Hunt, J. Booth, D. Thwaites, J. O’Toole, A. Vestergaard, J. Kallehauge, A. Kneebone and T. Eade (2015). Adaptive radiotherapy for bladder cancer using deformable image registration of empty and full bladder. IFMBE Proceedings.
Juneja, P., A. Kneebone, J. T. Booth, D. I. Thwaites, R. Kaur, E. Colvill, J. A. Ng, P. J. Keall and T. Eade (2015). “Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: A comparative study.” Radiation Oncology 10(1).
Kakavand, H., J. S. Wilmott, A. M. Menzies, R. Vilain, L. E. Haydu, J. H. Yearley, J. F. Thompson, R. F. Kefford, P. Hersey, G. V. Long and R. A. Scolyer (2015). “PD-L1 expression and tumor-infiltrating lymphocytes define different subsets of MAPK inhibitor-treated melanoma patients.” Clinical Cancer Research 21(14): 3140-3148.
Kan, C. W. S., V. M. Howell, M. A. Hahn and D. J. Marsh (2015). “Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.” Genes Chromosomes and Cancer 54(1): 1-19.
Kanthan, G. L., J. Drummond, G. P. Schembri, M. A. Izard and E. Hsiao (2015). “Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.” Clinical Nuclear Medicine.
Kao, S. C., M. Fulham, K. Wong, W. Cooper, H. Brahmbhatt, J. MacDiarmid, S. Pattison, J. O. Sagong, Y. Huynh, F. Leslie, N. Pavlakis, S. Clarke, M. Boyer, G. Reid and N. Van Zandwijk (2015). “A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma.” American Journal of Respiratory and Critical Care Medicine 191(12): 1467-1469.
Kaufman, K. L., Y. Jenkins, M. Alomari, M. Mirzaei, O. Giles Best, D. Pascovici, S. Mactier, S. P. Mulligan, P. A. Haynes and R. I. Christopherson (2015). “The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.” Oncotarget 6(38): 40981-40997.
Keall, P. J., J. Aun Ng, R. O’Brien, E. Colvill, C. Y. Huang, P. Rugaard Poulsen, W. Fledelius, P. Juneja, E. Simpson, L. Bell, F. Alfieri, T. Eade, A. Kneebone and J. T. Booth (2015). “The first clinical treatment with kilovoltage intrafraction monitoring (KIM): A real-time image guidance method.” Medical Physics 42(1): 354-358.
Khambalia, A. Z., C. E. Collins, C. L. Roberts, J. M. Morris, K. L. Powell, V. Tasevski and N. Nassar (2015). “High maternal serum ferritin in early pregnancy and risk of spontaneous preterm birth.” British Journal of Nutrition 114(3): 455-461.
Khoury, S. and N. Tran (2015). “Circulating microRNAs: Potential biomarkers for common malignancies.” Biomarkers in Medicine 9(2): 131-151.
Kim, E., E. M. Rath, V. H. M. Tsang, A. P. Duff, B. G. Robinson, W. B. Church, D. E. Benn, T. Dwight and R. J. Clifton-Bligh (2015). “Structural and functional consequences of succinate dehydrogenase subunit B mutations.” Endocrine-Related Cancer 22(3): 387-397.
Kirschner, M. B., Y. Y. Cheng, N. J. Armstrong, R. C. Y. Lin, S. C. Kao, A. Linton, S. Klebe, B. C. McCaughan, N. van Zandwijk and G. Reid (2015). “MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.” Molecular Oncology 9(3): 715-726.
Kirschner, M. B., E. Pulford, M. A. Hoda, A. Rozsas, K. Griggs, Y. Y. Cheng, J. J. B. Edelman, S. C. Kao, R. Hyland, Y. Dong, V. László, T. Klikovits, M. P. Vallely, M. Grusch, B. Hegedus, B. Dome, W. Klepetko, N. Van Zandwijk, S. Klebe and G. Reid (2015). “Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.” British Journal of Cancer 113(6): 963-969.
Kiyota, N., M. Schlumberger, K. Muro, Y. Ando, S. Takahashi, Y. Kawai, L. Wirth, B. Robinson, S. Sherman, T. Suzuki, K. Fujino, A. Gupta, S. Hayato and M. Tahara (2015). “Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer.” Cancer Science 106(12): 1714-1721.
Klebe, S., K. Griggs, Y. Cheng, J. Driml, D. W. Henderson and G. Reid (2015). “Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model.” Disease Markers 2015.
Knox, R. D., N. Luey, L. Sioson, A. Kedziora, A. Clarkson, N. Watson, C. W. Toon, C. Cussigh, S. Pincott, S. Pillinger, Y. Salama, J. Evans, J. Percy, M. Schnitzler, A. Engel and A. J. Gill (2015). “Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases.” Annals of Surgical Oncology 22(9): 2988-2996.
Kondrashova, O., C. J. Love, S. Lunke, A. L. Hsu, D. Bowtell, G. Chenevix-Trench, A. Green, P. Webb, A. DeFazio, D. Gertig, N. Traficante, S. Fereday, S. Moore, J. Hung, K. Harrap, T. Sadkowsky, N. Pandeya, M. Malt, A. Mellon, R. Robertson, T. Vanden Bergh, M. Jones, P. Mackenzie, J. Maidens, K. Nattress, Y. E. Chiew, A. Stenlake, H. Sullivan, B. Alexander, P. Ashover, S. Brown, T. Corrish, L. Green, L. Jackman, K. Ferguson, K. Martin, A. Martyn, B. Ranieri, J. White, V. Jayde, P. Mamers, L. Bowes, L. Galletta, D. Giles, J. Hendley, K. Alsop, T. Schmidt, H. Shirley, C. Ball, C. Young, S. Viduka, H. Tran, S. Bilic, L. Glavinas, J. Brooks, R. Stuart-Harris, F. Kirsten, J. Rutovitz, P. Clingan, A. Glasgow, A. Proietto, S. Braye, G. Otton, J. Shannon, T. Bonaventura, J. Stewart, S. Begbie, M. Friedlander, D. Bell, S. Baron-Hay, A. Ferrier, G. Gard, D. Nevell, N. Pavlakis, S. Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, N. Hacker, D. Marsden, G. Robertson, P. Beale, J. Beith, J. Carter, C. Dalrymple, R. Houghton, P. Russell, M. Links, J. Grygiel, J. Hill, A. Brand, K. Byth, R. Jaworski, P. Harnett, R. Sharma, G. Wain, B. Ward, D. Papadimos, A. Crandon, M. Cummings, K. Horwood, A. Obermair, L. Perrin, D. Wyld, J. Nicklin, M. Davy, M. K. Oehler, C. Hall, T. Dodd, T. Healy, K. Pittman, D. Henderson, J. Miller, J. Pierdes, P. Blomfield, D. Challis, R. McIntosh, A. Parker, B. Brown, R. Rome, D. Allen, P. Grant, S. Hyde, R. Laurie, M. Robbie, D. Healy, T. Jobling, T. Manolitsas, J. McNealage, P. Rogers, B. Susil, E. Sumithran, I. Simpson, K. Phillips, D. Rischin, S. Fox, D. Johnson, S. Lade, M. Loughrey, N. O’Callaghan, W. Murray, P. Waring, V. Billson, J. Pyman, D. Neesham, M. Quinn, C. Underhill, R. Bell, L. F. Ng, R. Blum, V. Ganju, I. Hammond, Y. Leung, A. McCartney, M. Buck, I. Haviv, D. Purdie, D. Whiteman, N. Zeps, P. M. Waring and G. R. Taylor (2015). “High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq.” PLoS ONE 10(11).
Lakhanpal, R., J. Yoong, S. Joshi, D. Yip, L. Mileshkin, G. M. Marx, T. Dunlop, E. J. Hovey, S. A. Della Fiorentina, L. Venkateswaran, M. H. N. Tattersall, S. Liew, K. Field, N. Singhal and C. B. Steer (2015). “Geriatric assessment of older patients with cancer in Australia-A multicentre audit.” Journal of Geriatric Oncology 6(3): 185-193.
Lam, T., M. M. K. Chan, A. N. Sweeting, S. M. C. De Sousa, A. Clements, M. S. Carlino, G. V. Long, K. Tonks, E. Chua, R. F. Kefford and D. R. Chipps (2015). “Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series.” Internal Medicine Journal 45(10): 1066-1073.
Law, M. H., D. T. Bishop, J. E. Lee, M. Brossard, N. G. Martin, E. K. Moses, F. Song, J. H. Barrett, R. Kumar, D. F. Easton, P. D. P. Pharoah, A. J. Swerdlow, K. P. Kypreou, J. C. Taylor, M. Harland, J. Randerson-Moor, L. A. Akslen, P. A. Andresen, M. F. Avril, E. Azizi, G. B. Scarrà, K. M. Brown, T. Dębniak, D. L. Duffy, D. E. Elder, S. Fang, E. Friedman, P. Galan, P. Ghiorzo, E. M. Gillanders, A. M. Goldstein, N. A. Gruis, J. Hansson, P. Helsing, M. Hočevar, V. Höiom, C. Ingvar, P. A. Kanetsky, W. V. Chen, M. T. Landi, J. Lang, G. M. Lathrop, J. Lubiński, R. M. MacKie, G. J. Mann, A. Molven, G. W. Montgomery, S. Novaković, H. Olsson, S. Puig, J. A. Puig-Butille, A. A. Qureshi, G. L. Radford-Smith, N. Van Der Stoep, R. Van Doorn, D. C. Whiteman, J. E. Craig, D. Schadendorf, L. A. Simms, K. P. Burdon, D. R. Nyholt, K. A. Pooley, N. Orr, A. J. Stratigos, A. E. Cust, S. V. Ward, N. K. Hayward, J. Han, H. J. Schulze, A. M. Dunning, J. A. N. Bishop, F. Demenais, C. I. Amos, S. MacGregor and M. M. Iles (2015). “Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.” Nature Genetics 47(9): 987-995.
Lawson, J. S., W. K. Glenn, D. Salyakina, W. Delprado, R. Clay, A. Antonsson, B. Heng, S. Miyauchi, D. D. Tran, C. C. Ngan, L. Lutze-Mann and N. J. Whitaker (2015). “Human Papilloma viruses and breast cancer.” Frontiers in Oncology 5(DEC).
Lee, D. E., X. Yue, W. G. Ibrahim, M. R. Lentz, K. L. Peterson, E. M. Jagoda, M. Kassiou, D. Maric, W. C. Reid and D. A. Hammoud (2015). “Lack of neuroinflammation in the HIV-1 transgenic rat: An [<sup>18</sup>F]-DPA714 PET imaging study.” Journal of Neuroinflammation 12(1).
Lew, R. M., L. Burnett, A. L. Proos and M. B. Delatycki (2015). “Tay-sachs disease: Current perspectives from australia.” Application of Clinical Genetics 8: 19-25.
Lewis, S. J. G., J. M. Shine, D. Brooks and G. M. Halliday (2015). Hallucinogenic mechanisms: Pathological and pharmacological insights. The Neuroscience of Visual Hallucinations: 119-149.
Lobb, E. A., J. Lacey, J. Kearsley, W. Liauw, L. White and A. Hosie (2015). “Living with advanced cancer and an uncertain disease trajectory: An emerging patient population in palliative care?” BMJ Supportive and Palliative Care 5(4): 352-357.
Lorigan, P., P. A. Ascierto, R. Dummer, A. M. Eggermont, K. T. Flaherty, C. Garbe, H. Gogas, A. Hauschild, R. F. Kefford, J. M. Kirkwood, J. Larkin, G. V. Long, M. Maio, G. A. McArthur, A. Ribas, C. Robert, D. Schadendorf, V. K. Sondak, J. D. Wolchok and A. M. Hudson (2015). “Expanded access programmes: Patient interests versus clinical trial integrity.” The Lancet Oncology 16(1): 15-17.
Luk, P. P., R. Vilain, O. Crainic, S. W. McCarthy, J. F. Thompson and R. A. Scolyer (2015). “Punch biopsy of melanoma causing tumour cell implantation: Another peril of utilising partial biopsies for melanocytic tumours.” Australasian Journal of Dermatology 56(3): 227-231.
Lynagh, M. C., T. Clinton-McHarg, A. Hall, R. Sanson-Fisher, W. Stevenson, C. Tiley and A. Bisquera (2015). “Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies.” Experimental Hematology and Oncology 4(1).
Madore, J., R. E. Vilain, A. M. Menzies, H. Kakavand, J. S. Wilmott, J. Hyman, J. H. Yearley, R. F. Kefford, J. F. Thompson, G. V. Long, P. Hersey and R. A. Scolyer (2015). “PD-L1 expression in melanoma shows marked heterogeneity within and between patients: Implications for anti-PD-1/PD-L1 clinical trials.” Pigment Cell and Melanoma Research 28(3): 245-253.
Maher, S. G., B. A. S. Bibby, H. L. Moody and G. Reid (2015). MicroRNAs and Cancer. Epigenetic Cancer Therapy: 67-90.
Mahon, K. L., H. M. Lin, L. Castillo, B. Y. Lee, M. Lee-Ng, M. D. Chatfield, K. Chiam, S. N. Breit, D. A. Brown, M. P. Molloy, G. M. Marx, N. Pavlakis, M. J. Boyer, M. R. Stockler, R. J. Daly, S. M. Henshall and L. G. Horvath (2015). “Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.” British Journal of Cancer 112(8): 1340-1348.
Mallawaaratchy, D. M., M. E. Buckland, K. L. McDonald, C. C. Y. Li, L. Ly, E. K. Sykes, R. I. Christopherson and K. L. Kaufman (2015). “Membrane Proteome Analysis of Glioblastoma Cell Invasion.” Journal of Neuropathology and Experimental Neurology 74(5): 425-441.
Manohar, M., S. D. Banister, C. Beinat, J. O’Brien-Brown and M. Kassiou (2015). “Recent advances in the development of sigma-1 receptor ligands.” Australian Journal of Chemistry 68(4): 600-609.
Marstaller, L., M. Williams, A. Rich, G. Savage and H. Burianová (2015). “Aging and large-scale functional networks: White matter integrity, gray matter volume, and functional connectivity in the resting state.” Neuroscience 290: 369-378.
Marzec, K. A., R. C. Baxter and J. L. Martin (2015). “Targeting insulin-like growth factor binding protein-3 signaling in triple-negative breast cancer.” BioMed Research International 2015.
Marzec, K. A., M. Z. Lin, J. L. Martin and R. C. Baxter (2015). “Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.” Oncotarget 6(29): 26583-26598.
Mattner, F., M. Quinlivan, I. Greguric, T. Pham, X. Liu, T. Jackson, P. Berghofer, C. J. R. Fookes, B. Dikic, M. C. Gregoire, F. Dolle and A. Katsifis (2015). “Radiosynthesis, in Vivo Biological Evaluation, and Imaging of Brain Lesions with [<sup>123</sup>I]-CLINME, a New SPECT Tracer for the Translocator Protein.” Disease Markers 2015.
McAuliffe, S., R. Brown, A. Catalano, P. J. Ho, N. Nassif, N. Woodland, D. Hart, C. Weatherburn, S. Yang, H. Suen, C. Paul, D. Joshua and J. Gibson (2015). “Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.” Leukemia and Lymphoma 56(9): 2714-2716.
McLachlan, J. M., D. L. Chan, M. A. Crumbaker and G. M. Marx (2015). “Neutrophil-lymphocyte ratio prior to steroids as a prognostic marker in men with metastatic castration-resistant prostate cancer.” Cancer Treatment Communications 4: 81-85.
McNulty, J. P., R. Lonergan, P. C. Brennan, M. G. Evanoff, R. O’Laoide, J. T. Ryan and N. Tubridy (2015). “Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.” Clinical Neuroradiology 25(3): 233-239.
Memari, N., A. Hayen, K. J. L. Bell, L. Rychetnik, R. L. Morton, K. McCaffery, J. F. Thompson, L. Irwig and R. M. Turner (2015). “How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?” Annals of Surgical Oncology 22: 1164-1171.
Menzies, A. M., M. T. Ashworth, S. Swann, R. F. Kefford, K. Flaherty, J. Weber, J. R. Infante, K. B. Kim, R. Gonzalez, O. Hamid, L. Schuchter, J. Cebon, J. A. Sosman, S. Little, P. Sun, G. Aktan, D. Ouellet, F. Jin, G. V. Long and A. Daud (2015). “Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.” Annals of Oncology 26(2): 415-421.
Menzies, A. M., V. G. Atkinson, M. P. Brown, M. S. Carlino, J. Cebon, A. Guminski, R. F. Kefford, G. V. Long, G. McArthur, C. M. McNeil, M. Millward and S. Sandhu (2015). “Sentinel node biopsy for melanoma: The medical oncology perspective.” Australian Family Physician 44(12): 875-876.
Menzies, A. M., J. S. Wilmott, M. Drummond, S. Lo, M. Lyle, M. M. K. Chan, J. F. Thompson, A. Guminski, M. S. Carlino, R. A. Scolyer, R. F. Kefford and G. V. Long (2015). “Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.” Cancer 121(21): 3826-3835.
Minocha, R., R. Kefford, P. Uribe, D. F. Sebaratnam and P. Fernández-Peñas (2015). “Diffuse melanosis cutis in the setting of BRAF<sup>V600E</sup> mutant melanoma and treatment with targeted therapies.” Australasian Journal of Dermatology 56(2): 128-130.
Moh, E. S. X., M. Thaysen-Andersen and N. H. Packer (2015). “Relative versus absolute quantitation in disease glycomics.” Proteomics – Clinical Applications 9(3-4): 368-382.
Munoz, L., M. E. Kavanagh, A. F. Phoa, B. Heng, N. Dzamko, E. J. Chen, M. R. Doddareddy, G. J. Guillemin and M. Kassiou (2015). “Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation.” European Journal of Medicinal Chemistry 95: 29-34.
Narlawar, R., E. L. Werry, A. M. Scarf, R. Hanani, S. W. Chua, V. A. King, M. L. Barron, R. N. Martins, L. M. Ittner, L. M. Rendina and M. Kassiou (2015). “First demonstration of positive allosteric-like modulation at the human wild type translocator protein (TSPO).” Journal of Medicinal Chemistry 58(21): 8743-8749.
Ngo, A. D., J. S. Chen, G. Figtree, J. M. Morris and C. L. Roberts (2015). “Preterm birth and future risk of maternal cardiovascular disease – is the association independent of smoking during pregnancy?” BMC Pregnancy and Childbirth 15(1).
Nippita, T. A., A. Z. Khambalia, S. K. Seeho, J. A. Trevena, J. A. Patterson, J. B. Ford, J. M. Morris and C. L. Roberts (2015). “Methods of classification for women undergoing induction of labour: A systematic review and novel classification system.” BJOG: An International Journal of Obstetrics and Gynaecology 122(10): 1284-1293.
Nippita, T. A., J. A. Trevena, J. A. Patterson, J. B. Ford, J. M. Morris and C. L. Roberts (2015). “Variation in hospital rates of induction of labour: A population-based record linkage study.” BMJ Open 5(9).
Olley, J., A. Blaszczynski and S. Lewis (2015). “Dopaminergic Medication in Parkinson’s Disease and Problem Gambling.” Journal of gambling studies / co-sponsored by the National Council on Problem Gambling and Institute for the Study of Gambling and Commercial Gaming 31(3): 1085-1106.
Parrilla, C., A. Minni, H. Bogaardt, G. F. Macri, M. Battista, R. Roukos, M. Pandolfini, G. Ruoppolo, G. Paludetti, L. D’Alatri and M. De Vincentiis (2015). “Pulmonary rehabilitation after total laryngectomy: A multicenter time-series clinical trial evaluating the provox xtrahme in HME-Naïve patients.” Annals of Otology, Rhinology and Laryngology 124(9): 706-713.
Pasquier, E., M. P. Tuset, S. Sinnappan, M. Carnell, A. Macmillan and M. Kavallaris (2015). “γ-Actin plays a key role in endothelial cell motility and neovessel maintenance.” Vascular Cell 7(1).
Patterson, J. A., D. O. Irving, J. P. Isbister, J. M. Morris, E. Mayson, C. L. Roberts and J. B. Ford (2015). “Age of blood and adverse outcomes in a maternity population.” Transfusion 55(11): 2730-2737.
Patterson, J. A., C. L. Roberts, J. P. Isbister, D. O. Irving, M. C. Nicholl, J. M. Morris and J. B. Ford (2015). “What factors contribute to hospital variation in obstetric transfusion rates?” Vox Sanguinis 108(1): 37-45.
Phoa, A. F., S. Browne, F. M. S. Gurgis, M. C. Åkerfeldt, A. Döbber, C. Renn, C. Peifer, B. W. Stringer, B. W. Day, C. Wong, M. Chircop, T. G. Johns, M. Kassiou and L. Munoz (2015). “Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling.” Biochemical Pharmacology 98(4): 587-601.
Rahman, W., T. Tu, M. Budzinska, P. Huang, L. Belov, J. S. Chrisp, R. I. Christopherson, F. J. Warner, D. S. Bowden, A. J. Thompson, D. G. Bowen, S. I. Strasser, D. Koorey, A. F. Sharland, J. Y. H. Yang, G. W. McCaughan and N. A. Shackel (2015). “Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays.” Transplantation 99(9): e120-e126.
Ramsdale, R., R. N. Jorissen, F. Z. Li, S. Al-Obaidi, T. Ward, K. E. Sheppard, P. E. Bukczynska, R. J. Young, S. E. Boyle, M. Shackleton, G. Bollag, G. V. Long, E. Tulchinsky, H. Rizos, R. B. Pearson, G. A. McArthur, A. S. Dhillon and P. T. Ferrao (2015). “The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.” Science Signaling 8(390): ra82.
Read, R. L., P. Stalley and J. F. Thompson (2015). “The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma.” Annals of Surgical Oncology 22(12): 4067-4072.
Reid, G. (2015). “MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets.” Journal of Thoracic Disease 7(6): 1031-1040.
Reilhac, A., A. Charil, C. Wimberley, G. Angelis, H. Hamze, P. Callaghan, M. P. Garcia, F. Boisson, W. Ryder, S. R. Meikle and M. C. Gregoire (2015). “4D PET iterative deconvolution with spatiotemporal regularization for quantitative dynamic PET imaging.” NeuroImage 118: 484-493.
Ricci, M., A. Mohamed, G. Savage, J. Boserio and L. A. Miller (2015). “The impact of epileptiform abnormalities and hippocampal lesions on retention of recent autobiographical experiences: Adding insult to injury?” Neuropsychologia 66: 259-266.
Ricci, M., A. Mohamed, G. Savage and L. A. Miller (2015). “Disruption of learning and long-term retention of prose passages in patients with focal epilepsy.” Epilepsy and Behavior 51: 104-111.
Roberts, C. L., C. S. Algert, J. M. Morris and J. B. Ford (2015). “Increased planned delivery contributes to declining rates of pregnancy hypertension in Australia: A population-based record linkage study.” BMJ Open 5(10).
Roberts, C. L., C. S. Algert, K. L. Rickard and J. M. Morris (2015). “Treatment of vaginal candidiasis for the prevention of preterm birth: A systematic review and meta-analysis.” Systematic Reviews 4(1).
Roberts, J. M., F. Jin, J. K. Thurloe, C. Biro, I. M. Poynten, S. N. Tabrizi, C. K. Fairley, D. J. Templeton, A. D. Carr, S. M. Garland, R. J. Hillman, A. M. Cornall, A. E. Grulich and A. Farnsworth (2015). “High reproducibility of histological diagnosis of human papillomavirus-related intraepithelial lesions of the anal canal.” Pathology 47(4): 308-313.
Roberts, M. P., V. Nguyen, M. E. Ashford, P. Berghofer, N. A. Wyatt, A. M. Krause-Heuer, T. Q. Pham, S. R. Taylor, L. Hogan, C. D. Jiang, B. H. Fraser, N. A. Lengkeek, L. Matesic, M. C. Gregoire, D. Denoyer, R. J. Hicks, A. Katsifis and I. Greguric (2015). “Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents.” Journal of Medicinal Chemistry 58(15): 6214-6224.
Roxby, D. N., N. Tran, P. L. Yu and H. T. Nguyen (2015). Experimenting with microbial fuel cells for powering implanted biomedical devices. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.
Sailly, M., R. Whiteley, J. W. Read, B. Giuffre, A. Johnson and P. Hölmich (2015). “Pubic apophysitis: A previously undescribed clinical entity of groin pain in athletes.” British Journal of Sports Medicine 49(12): 828-834.
Sanborn, J. Z., J. Chung, E. Purdom, N. J. Wang, H. Kakavand, J. S. Wilmott, T. Butler, J. F. Thompson, G. J. Mann, L. E. Haydu, R. P. M. Saw, K. J. Busam, R. S. Lo, E. A. Collisson, J. S. Hur, P. T. Spellman, J. E. Cleaver, J. W. Gray, N. Huh, R. Murali, R. A. Scolyer, B. C. Bastian and R. J. Cho (2015). “Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.” Proceedings of the National Academy of Sciences of the United States of America 112(35): 10995-11000.
Sargen, M. R., P. A. Kanetsky, J. Newton-Bishop, N. K. Hayward, G. J. Mann, N. A. Gruis, M. A. Tucker, A. M. Goldstein, G. Bianchi-Scarra, S. Puig and D. E. Elder (2015). “Histologic features of melanoma associated with CDKN2A genotype.” Journal of the American Academy of Dermatology 72(3): 496-507.e497.
Savage, G. (2015). Cognitive neuropsychological formulation. Neuropsychological Formulation: A Clinical Casebook: 221-239.
Schembri, G. P., P. J. Roach, D. L. Bailey and L. Freeman (2015). “Artifacts and anatomical variants affecting ventilation and perfusion lung imaging.” Seminars in Nuclear Medicine 45(5): 373-391.
Schneuer, F. J., N. Nassar, C. Guilbert, V. Tasevski, A. W. Ashton, J. M. Morris and C. L. Roberts (2015). “Evaluation of first trimester serum soluble endothelial cell-specific tyrosine kinase receptor in normal and affected pregnancies.” Journal of Maternal-Fetal and Neonatal Medicine 28(15): 1815-1821.
Scott, C. D. and W. Kiess (2015). “Soluble M6P/IGFIIR in the circulation.” Best Practice and Research: Clinical Endocrinology and Metabolism 29(5): 723-733.
Sérrière, S., C. Tauber, J. Vercouillie, C. Mothes, C. Pruckner, D. Guilloteau, M. Kassiou, A. Doméné, L. Garreau, G. Page and S. Chalon (2015). “Amyloid load and translocator protein 18kDa in APPswePS1-dE9 mice: A longitudinal study.” Neurobiology of Aging 36(4): 1639-1652.
Sethi, M. K. and S. Fanayan (2015). “Mass spectrometry-based N-glycomics of colorectal cancer.” International Journal of Molecular Sciences 16(12): 29278-29304.
Sethi, M. K. and S. Fanayan (2015). “Using single lectins to enrich glycoproteins in conditioned media.” Current Protocols in Protein Science 2015: 24.26.21-24.26.10.
Sethi, M. K., H. Kim, C. K. Park, M. S. Baker, Y. K. Paik, N. H. Packer, W. S. Hancock, S. Fanayan and M. Thaysen-Andersen (2015). “In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.” Glycobiology 25(10): 1064-1078.
Sethi, M. K., M. Thaysen-Andersen, H. Kim, C. K. Park, M. S. Baker, N. H. Packer, Y. K. Paik, W. S. Hancock and S. Fanayan (2015). “Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.” Journal of Proteomics 126: 54-67.
Shand, A. W., J. S. Chen, M. Schnitzler and C. L. Roberts (2015). “Incisional hernia repair after caesarean section: A population-based study.” Australian and New Zealand Journal of Obstetrics and Gynaecology 55(2): 170-175.
Shine, J. M., R. Keogh, C. O’Callaghan, A. J. Muller, S. J. Lewis and J. Pearson (2015). “Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson’s disease and visual hallucinations.” Proceedings. Biological sciences / The Royal Society 282(1798): 20142047.
Siddall, P. J., M. Lovell and R. Macleod (2015). “Spirituality: What is its role in pain medicine?” Pain Medicine (United States) 16(1): 51-60.
Sobral-Leite, M., J. Wesseling, V. T. H. B. M. Smit, H. Nevanlinna, M. H. van Miltenburg, J. Sanders, I. Hofland, F. M. Blows, P. Coulson, G. Patrycja, J. H. M. Schellens, R. Fagerholm, P. Heikkilä, K. Aittomäki, C. Blomqvist, E. Provenzano, H. R. Ali, J. Figueroa, M. Sherman, J. Lissowska, A. Mannermaa, V. Kataja, V. M. Kosma, J. M. Hartikainen, K. A. Phillips, F. J. Couch, J. E. Olson, C. Vachon, D. Visscher, H. Brenner, K. Butterbach, V. Arndt, B. Holleczek, M. J. Hooning, A. Hollestelle, J. W. M. Martens, C. H. M. van Deurzen, B. van de Water, A. Broeks, J. Chang-Claude, G. Chenevix-Trench, D. F. Easton, P. D. P. Pharoah, M. García-Closas, M. de Graauw, M. K. Schmidt, M. Aghmesheh, D. Amor, L. Andrews, Y. Antill, S. Armitage, L. Arnold, R. Balleine, A. Bankier, P. Bastick, J. Beesley, J. Beilby, B. Bennett, I. Bennett, G. Berry, A. Blackburn, M. Bogwitz, M. Brennan, M. Brown, M. Buckley, M. Burgess, J. Burke, P. Butow, K. Byron, D. Callen, I. Campbell, D. Chauhan, M. Chauhan, A. Christian, C. Clarke, A. Colley, D. Cotton, A. Crook, J. Cui, B. Culling, M. Cummings, S. J. Dawson, A. deFazio, M. Delatycki, R. Dickson, J. Dixon, A. Dobrovic, T. Dudding, T. Edkins, S. Edwards, M. Eisenbruch, G. Farshid, S. Fawcett, A. Fellows, G. Fenton, M. Field, F. Firgaira, J. Flanagan, J. Fleming, P. Fong, J. Forbes, S. Fox, J. French, M. Friedlander, C. Gaff, M. Gardner, M. Gattas, P. George, G. Giles, G. Gill, J. Goldblatt, S. Greening, S. Grist, E. Haan, K. Hardie, M. Harris, S. Hart, N. Hayward, S. Healey, L. Heiniger, J. Hopper, E. Humphrey, C. Hunt, P. James, M. Jenkins, A. Jones, R. Kefford, A. Kidd, B. Kiely, J. Kirk, J. Koehler, J. Kollias, S. Kovalenko, S. Lakhani, A. Leaming, J. Leary, J. Lim, G. Lindeman, L. Lipton, L. Lobb, G. Mann, D. Marsh, S. A. McLachlan, B. Meiser, C. Meldrum, R. Milne, G. Mitchell, B. Newman, E. Niedermayr, S. Nightingale, S. O’Connell, I. O’Loughlin, R. Osborne, N. Pachter, B. Patterson, L. Peters, K. Phillips, M. Price, L. Purser, T. Reeve, J. Reeve, R. Richards, E. Rickard, B. Robinson, B. Rudzki, M. Saleh, E. Salisbury, J. Sambrook, C. Saunders, J. Saunus, R. Sayer, E. Scott, R. Scott, C. Scott, R. Seshadri, A. Sexton, R. Sharma, A. Shelling, P. Simpson, M. Southey, A. Spurdle, G. Suthers, P. Sykes, M. Tassell, D. Taylor, J. Taylor, B. Thierry, S. Thomas, E. Thompson, H. Thorne, S. Townshend, A. Trainer, L. Tran, K. Tucker, J. Tyler, J. Visvader, L. Walker, I. Walpole, R. Ward, P. Waring, B. Warner, G. Warren, R. Williams, J. Wilson, I. Winship, K. Wu, M. A. Young, D. Bowtell, A. Green, P. Webb, A. de Fazio and D. Gertig (2015). “Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis.” BMC Medicine 13(1).
Spillane, A., R. Read and J. Thompson (2015). “Reply.” Australian Family Physician 44(12): 874-875.
Stark, M. S., K. Klein, B. Weide, L. E. Haydu, A. Pflugfelder, Y. H. Tang, J. M. Palmer, D. C. Whiteman, R. A. Scolyer, G. J. Mann, J. F. Thompson, G. V. Long, A. P. Barbour, H. P. Soyer, C. Garbe, A. Herington, P. M. Pollock and N. K. Hayward (2015). “The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis.” EBioMedicine 2(7): 671-680.
Suleiman, M. E., P. C. Brennan and M. F. McEntee (2015). “Diagnostic reference levels in digital mammography: Asystematic review.” Radiation Protection Dosimetry 167(4): 608-619.
Tembe, V., E. Martino-Echarri, K. A. Marzec, M. T. S. Mok, K. M. Brodie, K. Mills, Y. Lei, A. DeFazio, H. Rizos, E. Kettle, R. Boadle and B. R. Henderson (2015). “The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.” Cellular Signalling 27(9): 1763-1771.
Tembe, V., S. J. Schramm, M. S. Stark, E. Patrick, V. Jayaswal, Y. H. Tang, A. Barbour, N. K. Hayward, J. F. Thompson, R. A. Scolyer, Y. H. Yang and G. J. Mann (2015). “MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.” Pigment Cell and Melanoma Research 28(3): 254-266.
Thompson, J. F., S. S. Agarwala, B. M. Smithers, M. I. Ross, C. R. Scoggins, B. J. Coventry, S. J. Neuhaus, D. R. Minor, J. M. Singer and E. A. Wachter (2015). “Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.” Annals of Surgical Oncology 22(7): 2135-2142.
Tiffen, J. C., D. Gunatilake, S. J. Gallagher, K. Gowrishankar, A. Heinemann, C. Cullinane, K. Dutton-Regester, G. M. Pupo, D. Strbenac, J. Y. Yang, J. Madore, G. J. Mann, N. K. Hayward, G. A. McArthur, F. V. Filipp and P. Hersey (2015). “Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.” Oncotarget 6(29): 27023-27036.
Trieu, P. D., P. Brennan, B. Giuffre, C. Mello-Thoms, K. Tapia, N. Santangelo, H. Kim, K. Cameron, C. Hayter, G. Da Costa, J. Sterba and W. Lee (2015). “Evaluation of the effect of zoom function on lesion detection by soft-copy reading of screening mammograms.” Journal of Medical Imaging and Radiation Oncology 59(3): 292-299.
Tsang, V. H. M., L. J. Tacon, D. L. Learoyd and B. G. Robinson (2015). Pheochromocytomas in multiple endocrine neoplasia type 2. Recent Results in Cancer Research. 204: 157-178.
Vonhoff, C. R., A. Lochhead, S. Koustais, N. Watson, J. Andrici, J. Brewer and A. J. Gill (2015). “Differences in the Pathological Diagnosis and Repeat Craniotomy Rates in Cerebral Tumors Undergoing Biopsy or Resection in an Urban Versus Regional Center.” Medicine 94(47): e2131.
Wadt, K. A. W., L. G. Aoude, P. Johansson, A. Solinas, A. Pritchard, O. Crainic, M. T. Andersen, J. F. Kiilgaard, S. Heegaard, L. Sunde, B. Federspiel, J. Madore, J. F. Thompson, S. W. McCarthy, A. Goodwin, H. Tsao, G. Jönsson, K. Busam, R. Gupta, J. M. Trent, A. M. Gerdes, K. M. Brown, R. A. Scolyer and N. K. Hayward (2015). “A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.” Clinical Genetics 88(3): 267-272.
Wallace, D., J. A. Ng, P. J. Keall, R. T. O’Brien, P. R. Poulsen, P. Juneja and J. T. Booth (2015). “Determining appropriate imaging parameters for kilovoltage intrafraction monitoring: An experimental phantom study.” Physics in Medicine and Biology 60(12): 4835-4847.
Walton, C. C., J. M. Shine, L. Mowszowski, M. Gilat, J. M. Hall, C. O’Callaghan, S. L. Naismith and S. J. G. Lewis (2015). “Impaired cognitive control in Parkinson’s disease patients with freezing of gait in response to cognitive load.” Journal of Neural Transmission 122(5): 653-660.
Wargocki, P., W. Deng, A. G. Anwer and E. M. Goldys (2015). “Medically relevant assays with a simple smartphone and tablet based fluorescence detection system.” Sensors (Basel, Switzerland) 15(5): 11653-11664.
Watts, C. G., A. E. Cust, S. W. Menzies, E. Coates, G. J. Mann and R. L. Morton (2015). “Specialized surveillance for individuals at high risk for melanoma a cost analysis of a high-risk clinic.” JAMA Dermatology 151(2): 178-186.
Watts, C. G., M. Dieng, R. L. Morton, G. J. Mann, S. W. Menzies and A. E. Cust (2015). “Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: A systematic review.” British Journal of Dermatology 172(1): 33-47.
Wilkinson, S. M., S. D. Banister and M. Kassiou (2015). “Bioisosteric Fluorine in the Clandestine Design of Synthetic Cannabinoids.” Australian Journal of Chemistry 68(1): 4-8.
Williams, M., M. B. Kirschner, Y. Y. Cheng, J. Hanh, J. Weiss, N. Mugridge, C. M. Wright, A. Linton, S. C. Kao, J. James B. Edelman, M. P. Vallely, B. C. McCaughan, W. Cooper, S. Klebe, R. C. Y. Lin, H. Brahmbhatt, J. MacDiarmid, N. van Zandwijk and G. Reid (2015). “miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.” Oncotarget 6(27): 23480-23495.
Wilmott, J. S., A. J. Colebatch, H. Kakavand, P. Shang, M. S. Carlino, J. F. Thompson, G. V. Long, R. A. Scolyer and P. Hersey (2015). “Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.” Modern Pathology 28(7): 884-894.
Xue, A., S. M. Julovi, T. J. Hugh, J. S. Samra, M. H. F. Wong, A. J. Gill, C. W. Toon and R. C. Smith (2015). “A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas.” Pancreatology 15(4): 397-404.
Yan, E. B., T. Frugier, C. K. Lim, B. Heng, G. Sundaram, M. Tan, J. V. Rosenfeld, D. W. Walker, G. J. Guillemin and M. C. Morganti-Kossmann (2015). “Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.” Journal of Neuroinflammation 12(1).
Yan, J. F., H. Kim, S. K. Jeong, H. J. Lee, M. K. Sethi, L. Y. Lee, R. C. Beavis, H. Im, M. P. Snyder, M. Hofree, T. Ideker, S. L. Wu, Y. K. Paik, S. Fanayan and W. S. Hancock (2015). “Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues.” Journal of Proteome Research 14(12): 4995-5006.
Yoon, P. D., V. Chalasani and H. H. Woo (2015). “Systematic review and meta-analysis on management of acute urinary retention.” Prostate Cancer and Prostatic Diseases 18(4): 297-302.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.